ALBERT

Keywords: hydrogels ; crosslinking ; degradable ; gamma (γ)-irradiation ; sterilization ; sterility assurance ; antibacterial ability ; jojoba ; Simmondsia ; chemistry ; liquid wax ; biology ; toxicity ; pharmaceutical/industrial uses ; articular cartilage ; mechanical properties ; tribological properties ; antibacterial ; pathogens ; infectious diseases ; silver nanoparticles ; wound care ; wound dressings ; polymers ; gelatin ; nanofibers ; sponges ; Ag/RGO nanocomposites ; green preparation ; anticancer performance ; potential mechanism ; oxidative stress ; hydrogel ; poloxamer 407 polymer ; poloxamer 407 gel ; transungual drug delivery ; onychomycosis ; ungual penetration enhancer ; Terbinafine ; diafiltration ; SAXS ; aromatic interactions ; poly(sodium 4-styrenesulfonate) ; chlorpheniramine ; polyelectrolyte ; aggregation ; coaxial electrospinning ; extracellular matrix ; myelination ; oligodendrocyte ; water-soluble materials ; orthokeratology lens ; protein deposition ; optical characteristics ; rubbing ; chitosan ; kenaf ; nanocrystalline cellulose ; platelet lysate ; wound healing ; carbohydrate polymers blends ; functional food ; antioxidant activity ; co-microencapsulation ; spray drying ; bacteria viability (Bacillus clausii) ; probiotics ; itraconazole ; self-emulsifying nanovesicles ; transungual ; anti-fungal ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KND Manufacturing industries::KNDP Pharmaceutical industries

Keywords: systemic sclerosis ; scleroderma ; interstitial lung disease ; pulmonary function tests ; high-resolution computed tomography ; rheumatic ; pulmonary arterial hypertension ; targeted therapy ; systemic lupus erythematosus ; airway disease ; shrinking lung syndrome ; diffuse alveolar hemorrhage ; pleurisy ; infection ; cardiopulmonary exercise testing ; osteopontin ; connective tissue diseases ; pulmonary involvement ; microvascular involvement ; nailfold capillaroscopy ; rheumatoid arthritis ; interstitial lung diseases ; CX3CL1/fractalkine ; CX3CR1 ; M1 macrophage ; M2 macrophage ; SKG mice ; heart failure ; 3D-echocardiography ; ventricular function ; outcome ; ventricular-arterial coupling ; antifibrotic agents ; COVID-19 ; IPF ; progressive fibrosing ILD ; UIP ; pharmacological interactions ; fibromyalgia ; gastrointestinal symptoms ; probiotic ; VSL#3® ; efficacy ; tolerability ; polymyalgia rheumatica ; vagus nerve stimulation ; inflammatory response ; PMR ; t-vns ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: Hedychium ; traditional medicine ; coronarin D ; villosin ; anti-acetylcholinesterase ; antidiabetic ; anti-inflammatory ; antimicrobial ; antioxidant ; antitumor ; Genista tridentata ; Pterospartum tridentatum ; isoflavones ; flavonols ; genistein ; biochanin A ; rutin ; daidzein ; inflammatory bowel disease ; Crohn’s disease ; ulcerative colitis ; extra-intestinal manifestations ; orofacial granulomatosis ; tag-like lesions ; cobblestoning ; mucogingivitis ; lip swelling ; aphthous stomatitis ; Angelicae Sinensis Radix ; Danggui ; granules ; herb ; multivariate analysis ; ultra-performance liquid chromatography ; Tai Chi ; qigong ; immune system ; immunity ; inflammation ; telemedicine ; remote monitoring ; GER-e-TEC ; elderly patient ; artificial intelligence ; geriatric syndromes ; detection of the precursory signs of decompensation of geriatric syndromes ; renal cell cancer ; genomic landscape ; targeted therapy ; tumor evolution ; tumor heterogeneity ; allergic rhinitis ; quercetin ; human CD4+ T cells ; Th1/Th2 cytokine balance ; modulation ; in vitro ; intravascular catheter ; CRBSI ; biofilm ; CVC ; antifouling ; chromone ; tumor specificity ; QSAR analysis ; apoptosis ; cell cycle analysis ; contrast-enhanced ultrasound ; hepatocellular carcinoma ; LI-RADS ; chronic liver disease ; granuloma annulare ; granulomatous disorders of the skin ; inflammatory skin conditions ; medical dermatology ; biliary tract cancer ; cholangiocarcinoma ; PARP ; BRCA ; olaparib ; rucaparib ; liver cancer ; pancreatic adenocarcinoma ; pancreatic cancer ; sarcoidosis ; superior vena cava syndrome ; venous thrombosis ; RUCAM ; Roussel Uclaf Causality Assessment Method ; diagnostic algorithm ; iDILI ; iDrug induced liver injury ; DILI ; HILI ; herb induced liver injury ; Stachys L. ; traditional uses ; pharmacological activities ; phytochemicals ; bioactive compounds ; Kampo formulae ; alkaline extract of Sasa sp. ; pine cone extract ; povidone-iodine ; HSV ; HIV ; loss of infectivity ; solubilization method ; diaphragmatic breathing ; abdominal breathing ; breathing exercise ; systematic review ; randomized controlled trial ; respiratory function ; auricular acupuncture ; preoperative anxiety ; protocol ; randomized controlled trials ; meta-analysis ; boiogito ; knee osteoarthritis ; rat ; Yokukansan ; fentanyl ; transient receptor potential ankyrin 1 (TRPA1) channel ; phosphorylated extracellular signal-regulated kinase (pERK) ; whole-cell patch-clamp recording ; herbal medicine ; calcium metabolism ; bone metabolism ; protease ; osteoclast ; macrophage ; RANKL ; LPS ; TLR4 ; TREM2 ; bic Book Industry Communication::M Medicine

Keywords: extracellular vesicle ; precision oncology ; cancer biomarker ; prostate cancer ; drug delivery ; extracellular vesicles ; lysosome ; nanocarriers ; ultrasound ; size exclusion chromatography ; differential ultracentrifugation ; head and neck squamous cell carcinoma (HNSCC) ; exosomes ; cancer ; biomarker ; diagnostic ; therapy ; liquid biopsy ; small extracellular vesicles (sEV) ; tumor-derived exosomes (TEX) ; melanoma cell-derived exosomes (MTEX) ; proteomics ; tumor microenvironment ; biomarkers ; ectosomes ; neoplasia ; microvesicles ; small extracellular vesicles ; isolation ; purification ; size-exclusion chromatography ; ultracentrifugation ; sucrose density cushion ; lymph node ; spleen ; solid tissue ; microvesicle ; exosome ; cancer therapeutic ; drug carrier ; flow cytometry ; immunophenotyping ; swarm detection ; tumor-associated macrophages ; macrophage polarization ; mannose receptor ; HIV-1 Nef ; glioblastoma ; microRNA ; immunoprecipitation ; CD44 ; human milk ; nutrient ; microbiota ; microRNAs ; nanocommunicator ; diagnostic biomarker ; drug delivery vehicle ; personalized cancer immunotherapy ; therapeutic agents ; cell-to-cell communication ; ionising radiation ; non-targeted effects ; signalling ; imaging flow cytometry ; biomarker reservoirs ; cancer diagnostics ; disease monitoring ; large EVs ; ovarian cancer cells ; ES-2 ; OAW-42 ; adipose tissue origin mesenchymal stem cells ; n/a ; bic Book Industry Communication::M Medicine

Keywords: thyroid carcinoma ; prophylactic central lymph node dissection ; lymph node metastases ; RET ; medullary thyroid carcinoma ; clinical management ; variants of uncertain significance ; differentiated thyroid cancer ; papillary thyroid cancer ; minimal extrathyroidal extension ; radioactive iodine therapy ; prognosis ; TNM ; histology ; multifocality ; lymph node metastasis ; vascular invasion ; autoimmune thyroid diseases ; radioiodine refractory ; Lenvatinib ; 18F-FDG-PET/CT ; cost-benefit analysis ; economics ; medical ; thyroid neoplasms ; radiomics ; ultrasound ; magnetic resonance imaging ; computer tomography ; prediction ; classification ; angiogenic microenvironment ; prognostic factors ; antiangiogenic therapy ; therapeutic target ; tumor microenvironment ; tumor behavior ; proliferation pathways ; cell cycle control pathways ; angiogenesis process ; thyroid cancer ; Gal-3 expression ; NIFTP ; EFVPTC ; lymphocytic thyroiditis (LT) ; immunohistochemical (IHC) analysis ; molecular imaging ; theranostics ; companion diagnostics ; immunoPET ; anaplastic thyroid cancer ; poorly thyroid cancer ; genetic landscape ; genetically guided therapy ; fluorodeoxyglucose F18 (18F-FDG) ; positron emission tomography (PET) ; magnetic resonance imaging (MRI) ; recurrence ; neoplasm metastasis ; thyroid surgery ; hypoparathyroidism ; fluorescence-guided surgery ; near-infrared autofluorescence ; PRKAR1A ; PKA ; Carney complex ; cAMP ; bone metastasis ; metastasectomy ; stereotactic radiosurgery ; ultrasound imaging ; thyroid nodule ; fine-needle aspiration ; papillary thyroid carcinoma ; lobectomy ; operative extent ; CONUT score ; tyrosine kinase inhibitors ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology

Keywords: law; medicine; medico legal; bioethics and health law; ethics; philosophy ; bic Book Industry Communication::L Law ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAD Bio-ethics ; bic Book Industry Communication::H Humanities::HP Philosophy

Keywords: chronic intestinal pseudo-obstruction ; parenteral nutrition ; pediatrics ; myopathy ; neuropathy ; IBS ; microbiota ; visceral hypersensitivity ; colorectal motility ; inflammatory bowel disease ; Crohn’s disease ; ulcerative colitis ; anti-TNF ; ustekinumab ; vedolizumab ; postoperative complications ; surgery ; preoperative therapy ; biologic therapy ; bio-naïve ; IBD ; pro-inflammatory cytokines ; lymphocyte migration ; treatment ; inflammatory bowel diseases ; biologic treatment ; combination ; n/a ; bic Book Industry Communication::M Medicine

Keywords: neurorehabilitation ; cognitive enhancement in children ; tech mediated rehabilitation ; developmental coordination disorders ; virtual reality ; telerehabilitation ; specific learning disorders ; cerebral palsy ; well-being ; dyslexia ; rhythm ; music therapy ; intervention ; developmental dyslexia ; new technologies ; augmented reality ; good practices ; Delphi method ; rehabilitation ; remote intervention ; children ; age ; severity ; improvement ; follow-up ; n/a ; bic Book Industry Communication::M Medicine

Keywords: human ; neuromodulation ; neurorehabilitation ; non-invasive ; spinal cord injury ; transcutaneous spinal cord stimulation ; evoked potentials motor ; motor activity ; spinal cord stimulation ; spinal reflexes ; voluntary ankle control ; walking ; hand training ; combined intervention ; cervical spinal cord ; activity-based therapy ; gait ; locomotion ; paraplegia ; task-specific training ; tetraplegia ; use-dependent plasticity ; antispasmodic ; electrical stimulation ; pendulum test ; intensity effect ; muscle strength effect ; cervical ; corticospinal pathway ; spinal reflex ; electrically evoked spinal motor potentials ; cervical spinal cord injury ; motor evoked potentials ; automation ; electromyography ; noninvasive ; Parkinson’s disease ; posterior root-muscle reflexes ; spasticity ; transcutaneous ; biophysics ; H reflex ; M wave ; posterior root-muscle reflex ; posterior root stimulation ; spine alignment ; spinal cord ; spine ; spinal stimulation ; corticospinal tract ; functional connectivity ; movement ; sensorimotor networks ; task dependence ; interlimb coordination ; rehabilitation ; neurophysiology ; Hoffmann (H)-reflex ; motor-evoked potential ; electroencephalography ; event-related desynchronisation ; posterior root muscle reflex ; evoked potentials ; lumbar spinal cord ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJN Neurology & clinical neurophysiology

Keywords: MPC polymer ; dry eye ; ocular surface ; lacrimal fluid ; mucin ; 3D bioprinting ; cornea ; retina ; ophthalmology ; tissue regeneration ; electrospinning ; conjunctiva ; decellularized tissue matrix ; small intestinal submucosa ; urinary bladder matrix ; polycaprolactone ; fiber ; tissue engineering ; stratification ; conjunctival epithelial cells ; hydrogel ; keratoplasty ; scaffold ; collagen ; advanced therapy medicinal product ; ATMP ; cell therapy ; gene therapy ; eye ; ocular ; regulatory ; marketing authorization ; double-crosslinking ; carbodiimide ; glutaraldehyde ; sodium metabisulfite ; sodium borohydride ; EDC/NHS ; stem cells ; retinal diseases ; optic nerve diseases ; cell replacement ; cell sources ; advanced therapies ; ocular mucosa ; blindness ; CLET ; limbal niche ; limbal stem cell ; LSCD ; mesenchymal stem cell transplantation ; MSCT ; corneal limbus ; decellularized xenograft ; recellularization ; mesenchymal stem cells ; n/a ; bic Book Industry Communication::M Medicine

Keywords: older adults ; polypharmacy ; internal medicine ward ; community pharmacy ; drug disposal ; unused medication ; environment ; awareness ; practice ; ambulatory care facilities ; health workforce ; pharmacists ; Taiwan ; Commonwealth Partnerships for Antimicrobial Stewardship (CwPAMS) ; National Health Service (NHS) ; Chief Pharmaceutical Officer’s Global Health Fellowship ; CPhOGH Fellows ; CwPAMS ; pharmacy ; fellowship ; health partnerships ; antimicrobial resistance (AMR) ; global health ; leadership ; non-prescription medicines ; emergency contraception ; community pharmacies ; information gathering ; availability ; pricing ; mystery calls ; ulipristal acetate ; levonorgestrel ; Germany ; e-prescription ; prescription writing ; Jazan ; Saudi Arabia ; prescription errors ; medicine consumption ; defined daily dose ; adolescents and young adults ; cancer patients ; fragility ; pain ; MUR ; medication review ; barriers ; pharmacist ; pregabalin ; abuse ; community pharmacists ; reproductive health ; contraception ; emergency contraceptives ; patient education ; biosensing technology ; digital medicine system ; medication adherence ; medication event monitoring system ; nonadherence ; prescription opioids ; mortality ; standardized mortality ratio ; underlying cause of death ; prescriptions ; community pharmacy services ; emergency prescribing ; pharmacy practice ; pharmacy law and regulation ; COVID-19 ; additional monitoring ; black triangle ; adverse event reporting ; pharmacovigilance ; intervention ; outcomes ; systematic review ; pharmacy education ; decision to study in pharmacy ; selecting pharmacy as a first choice ; pharmacogenomics ; learning activity ; asynchronous learning ; virtual learning ; student survey ; Program of All-Inclusive Care for the Elderly ; adverse drug events ; medication-related problems ; drug-related problems ; medication safety ; Medicare ; Medicaid ; financial management ; pharmacy management ; business ; entrepreneurship ; pharmacy students ; perception ; attitudes ; ability ; interprofessional ; simulation ; acute care ; nursing ; students ; standardized patients ; high fidelity ; SPICE-R2 ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KND Manufacturing industries::KNDP Pharmaceutical industries

Keywords: Dentistry ; Prosthodontics ; Implant ; dentistry ; Digital ; technology ; Dental ; materials ; Rapid ; prototyping ; CAD/CAM ; Optical ; scanning ; 3D ; printing ; Translational ; research ; bic Book Industry Communication::M Medicine

Keywords: retina ; inherited retinal diseases ; syndrome ; Turner syndrome ; mosaicism ; ring chromosomes ; growth hormone deficiency ; pituitary microadenoma ; clinical genetics ; early onset ataxia ; dystonia ; neurodevelopment ; network analysis ; bioinformatics ; ataxia ; phenotype ; child ; NGS ; next generation sequencing ; inborn errors of metabolism ; lysosomal disorders ; neuromuscular disease ; genetic testing ; whole exome sequencing ; Prader–Willi syndrome ; imprinting disorder ; recombinant human growth hormone ; insulin-like growth factor 1 ; HMGLD ; HMGCL ; HMG-CoA lyase deficiency ; inherited metabolic diseases ; familial hearing loss ; multiple diagnoses ; non-syndromic hearing loss ; ACTG1 ; MYH9 ; genetic counselling ; rare diseases ; professional recognition ; hearing loss ; genetic diagnosis ; SLC26A4 ; DFNB4 ; Tuvinians ; Altaians ; Southern Siberia ; Russia ; GSDME ; DFNA5 ; single-exon CNV ; n/a ; bic Book Industry Communication::M Medicine

Keywords: xerostomia ; dry mouth ; protein–protein interaction ; drug target ; head and neck cancer ; Sjögren’s Syndrome ; major histocompatibility complex (MHC) ; human leukocyte antigen (HLA) ; autoantigens ; T cells ; E-cadherins ; salivary glands ; morphogenesis ; EMT ; Sjögren’s syndrome ; autoimmunity ; hydrogen peroxide ; adrenaline ; blood loss ; tonsillectomy ; fibrosis ; pleomorphic adenoma ; epithelial–mesenchymal transition ; carcinoma ex-pleomorphic adenoma ; 99mTc-interleukin-2 ; activated lymphocytes ; inflammation imaging ; Sjögren syndrome ; nuclear medicine ; radiopharmaceuticals ; PET ; SPECT ; Follistatin-like 1 protein ; TGF-β1 ; SMAD2/3 ; fluoride ; sodium fluoride ; n/a ; bic Book Industry Communication::M Medicine

Keywords: BTG1 ; endometriosis ; human endometrial stromal cells ; endometrium ; uterus ; purinergic signaling ; ATP ; pathogenesis ; genetics ; epigenetics ; immunology ; ion channels ; etiology ; CFTR ; aquaporin ; chloride channels ; biomarker ; angiogenesis ; cytokines ; urinary biomarkers ; genetic polymorphisms ; SNPs ; aetiology ; Mediterranean population ; Sardinian population ; peritoneal fluid ; microenvironment ; precision medicine ; bic Book Industry Communication::M Medicine

Keywords: pharmacogenomics ; return of results ; genetic counseling ; qualitative ; pharmacogenetics ; implementation ; pharmacogenetics service ; screening ; pre-emptive ; personalized medicine ; precision medicine ; community pharmacy ; pharmacogenomic testing ; genetic privacy ; pharmaco-economics ; polymorphisms ; pharmacogenes ; pharmacogenomic ; machine learning ; adaptation ; human evolution ; US Food and Drug Administration ; clinical actionability ; clinical translation ; chronic kidney disease ; CYP3A5 ; polymorphism ; progression ; pharmacogenomics (PGx) ; pediatrics ; best practice alerts (BPAs) ; electronic health records (EHR) ; genomic indicators ; clinical decision support (CDS) ; phenotype ; genotype ; polypharmacy ; chronic disease ; medication management ; electronic medical record ; artificial intelligence ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: pelvic ring fracture ; PCCD ; position ; associated injuries ; geriatric trauma ; scoring ; polytrauma ; ISS ; AIS ; geriatric patients ; orthogeriatric ; E-bike injuries ; outcome ; injury pattern comparison ; traumatic injury ; reactive oxygen species ; phagocytosis ; CD14 ; CD16 ; CD62L ; fMLP ; PMA ; emergency surgery ; trauma team competence ; trauma system ; life-saving intervention ; trauma ; non-invasive external pelvic stabilizers ; bleeding ; pelvic fractures ; post mortem analysis ; biomechanical force ; pneumatic pelvic sling VBM® ; T-POD® ; cloth sling ; SAM Sling® ; trauma victims ; prehospital death ; Injury Severity Score (ISS) ; hemorrhage ; shock ; resuscitation ; coagulopathy ; oxygen transport ; endotheliopathy ; microcirculation ; macrocirculation ; orthopaedic trauma ; nutritional deficiencies ; vitamins ; lower extremity ; wound complications ; nutrition wound healing ; platelets ; immune system ; posttraumatic organ failure ; posttraumatic lung dysfunction ; posttraumatic hyperinflammation ; I-FABP ; biomarker ; intestinal damage ; hemorrhagic shock ; major trauma ; bic Book Industry Communication::M Medicine

Keywords: oxyhemoglobin level ; state anxiety ; task performance ; heart rate ; human ; asymmetry ; sex difference ; MRI ; volumetry ; cerebellum ; ferret ; lateralization ; side bias ; fish ; methodological artefacts ; symmetry ; non-human primate ; Old World monkey ; evolution ; evolutionary expansion ; gyrification ; structural asymmetry ; language laterality ; topological data analysis ; persistent homology ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: Medicina ; Tossicologia ; Farmacologia ; bic Book Industry Communication::M Medicine

Keywords: cross-sectional study ; dry eye disease ; systemic comorbidity ; graves’ ophthalmopathy ; inflammation ; meibomian glands ; morphological changes ; meibomian gland dysfunction ; ocular surface disease ; dry eye symptoms ; questionnaire ; Bangladesh ; global health ; epidemiology ; aqueous-deficient dry eye ; meibomian gland ; intense pulsed light ; severe keratitis ; hyaluronan ; hylan A ; multicenter ; randomized trial ; gabapentin ; dry eye ; neuropathic pain ; diabetes ; neuropathic keratopathy ; neuropathy ; nerve growth ; neurotrophic ; Houttuynia ; ultrasonic atomization ; meibography ; meiboscore ; TRPM8 agonist ; cryosim-3 ; fatty acids ; vitamin D ; brief-type self-administered diet history questionnaire ; Japanese ; bic Book Industry Communication::M Medicine

Keywords: saffron ; affron® ; depression ; anxiety ; antioxidant ; crocins ; glucose ; β-pancreatic cells ; insulin ; pck1 ; neuroprotective activity ; P2X7 receptor ; fraction ; flumazenil ; rat ; Crocus sativus ; cancer ; anticancer activity ; chemoprevention ; clinical trials ; patents ; anesthetic ketamine ; memory ; Crocus sativus L. ; schizophrenia ; crocetin ; pubertal testis ; X-rays ; radiotherapy ; fertility preservation ; SIRT1 ; HuR ; oxidative stress ; autophagy ; crocin ; picrocrocin ; safranal ; dietary supplement ; nutraceutical ; Crocus sativus L. (Iridaceae) ; reversed-phase UPLC ; metabolomics ; HR MS ; inflammatory bowel disease ; gut microbiota ; colitis ; cytokines ; colorectal cancer ; HCT116 ; MLH1 ; MSH3 ; DNA damage and repair ; apoptosis ; n/a ; bic Book Industry Communication::M Medicine

Keywords: ripasudil ; suture trabeculotomy ab interno ; Schlemm’s canal incision ; aqueous outflow ; open-angle glaucoma ; glaucoma ; inflammation ; oxidative stress ; phenotype ; polymorphism ; susceptibility ; intraocular pressure ; ocular inflammation ; cornea biomechanics ; Corvis® ST ; subclinical keratoconus ; ocular hypertension ; tears ; miRNAs ; next generation sequencing ; biomarkers ; genes ; signaling pathways ; apoptosis ; neurodegeneration ; glaucoma suspect ; lamina cribrosa ; optical coherence tomography angiography ; peripapillary vessel density ; OCTA ; vessel density ; disc ; peripapillary ; NTG ; BRVO ; corneal hysteresis ; corneal biomechanics ; ocular biomarkers ; deep learning ; perimetry ; optic nerve ; obesity ; risk factor ; young adults ; multifocal visual evoked potentials ; mfVEP ; physical exercise ; sport ; acrobatic gymnastics ; baseline intraocular pressure ; central corneal thickness ; ocular health ; tumbling skills ; hand balance ; cytokines ; BDNF ; VEGF ; fractalkine ; microglia ; saffron ; crocin ; retinal glial cells ; microperimetry ; OCT ; macula ; structure ; function ; correlation ; retina ; inner ; outer ; macular segmentation ; optical coherence tomography-angiography ; vascular density ; blood flow ; biomarker ; myopia ; n/a ; bic Book Industry Communication::M Medicine

Keywords: Alzheimer disease ; expression quantitative trait loci (eQTL) ; rare variants ; set-based eQTL ; SKAT-O ; pathways ; immune system ; inflammation ; ROSMAP ; ADNI ; complement ; complement receptor 1 ; clusterin ; late-onset Alzheimer’s disease ; genetics ; neuroinflammation ; Alzheimer’s disease ; cytokines and growth factors ; genome-wide association study (GWAS) ; Polygenic Risk Score (PRS)-based analysis ; TOMM40 gene ; RNA transcription ; pseudogene ; mitochondrial dysfunction ; ITIM ; ITAM ; SIGLEC14 ; SIGLEC5 ; copy number variation ; CNV ; GWAS ; long non-coding RNA ; biomarkers ; peripheral system ; amyloid β ; tau ; APOE ; TREM2 ; OMICS ; therapeutics ; pairwise feature correlation ; feature reduction ; machine learning ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: bic Book Industry Communication::M Medicine

Keywords: cell adhesion ; plasma medicine ; oncology ; cold atmospheric plasma ; selectivity ; plasma-treated liquid ; dielectric barrier discharge ; pancreatic cancer ; pancreatic stellate cells ; immunogenic cell death ; dendritic cells ; cell communication ; extracellular matrix (ECM) ; reactive oxygen and nitrogen species (ROS) ; tumour microenvironment (TME) ; extracellular vesicles ; communication junctions ; three-dimensional in vitro culture models ; apoptosis ; breast cancer ; genome-wide expression ; reactive oxygen species ; anticancer drugs ; screening ; tumor spheroids ; combination therapy ; kINPen ; reactive oxygen and nitrogen species ; ROS ; cancer ; non-thermal atmospheric pressure plasma (NTP) ; indirect treatment ; plasma-treated phosphate-buffered saline ; electroporation ; electric pulses ; pulsed electric field amplitude ; melanoma ; long-lived reactive species ; bone cancer ; osteosarcoma ; reactive species ; plasma-activated liquid ; Ringer’s saline ; organotypic model ; nonthermal biocompatible plasma ; soft jet plasma ; human glioblastoma ; p38/MAPK pathway ; tissue penetration ; non-thermal plasma ; non-invasive plasma treatment (NIPP) ; cervical intraepithelial neoplasia (CIN) ; Raman imaging ; Raman microspectroscopy ; Plasma lipid interactions ; cold physical plasma ; radiation therapy ; radio-frequency discharge ; PARP-inhibitor ; olaparib ; DNA-damage ; gold quantum dots ; plasma ; nanomaterials ; cellular uptake ; invasiveness ; cold atmospheric pressure plasma ; plasma-activated Ringer’s lactate solution ; ovarian cancer ; cytotoxicity ; plasma-activated liquids ; multicellular tumor spheroids ; long-lived reactive oxygen and nitrogen species ; high frequency electrosurgery ; plasma treatment ; cold atmospheric plasma (CAP) ; free radicals ; cancer selectivity ; cervical cancer treatment ; cervical intraepithelial neoplasia ; cholangiocarcinoma ; cold plasma ; innovative therapy ; tumor cells ; macrophages ; plasma selectivity ; plasma jet ; n/a ; bic Book Industry Communication::M Medicine

Keywords: sonodynamic therapy ; carbon doped titanium dioxide ; sonosensitizers ; ultrasound ; cancer treatment ; breast cancer treatment ; radiotherapy ; hematological malignancies ; oxidative stress ; lymphoma ; leukemia ; multiple myeloma ; apoptosis ; mitochondria ; ultraviolet-C (UVC) ; withanolide ; combined treatment ; oral cancer ; DNA damage ; cancer therapy ; immune system ; Hypericum perforatum ; hyperforin ; reactive oxygen species ; pH regulation ; tumor prevention ; tumor therapy ; cancerogenesis ; inflammatory signaling ; natural compounds ; pancreatic cancer ; antitumor agents ; coordination polymers ; bioinorganic chemistry ; cold atmospheric plasma ; reactive oxygen and nitrogen species ; nitrite ; cancer stem cells ; chemoresistance ; glutathione ; lipid peroxidation ; ZEB-1 ; GPX4 ; ferroptosis ; HO-1 ; Nrf2 ; cancer progression ; patients ; therapy ; prognosis ; biomarker ; Eprenetapopt ; Erastin ; glutathione (GSH) ; SLC7A11 ; iron ; NRF2 ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology

Keywords: ultrasonic vocalization ; maternal immune activation ; autism ; communication ; rat ; sex differences ; social play ; rats ; anxiety ; observational fear learning ; USV ; maternal separation ; pup ; vasopressin antagonists ; righting reflex ; negative geotaxis ; ACTH ; corticosterone ; Brattleboro rat ; larynx ; female ; male ; 50-khz ultrasonic vocalizations (USVs) ; individual differences ; chronic variable stress (CVS) ; dopamine ; nucleus accumbens ; microdialysis ; evolution of vocalization ; 22 kHz calls ; 50 kHz calls ; infant isolation calls ; emotional arousal ; mesolimbic dopaminergic system ; mesolimbic cholinergic system ; hedonia ; ultrasonic vocalizations ; cognitive development ; respiration ; brain oscillations ; Cav1.2 ; calcium ; animal model ; rough-and-tumble play ; social approach ; playback ; social contact call ; alarm call ; social buffering ; distress ; emotional contagion ; fear contagion ; aversive state ; automated scoring ; addiction ; mental health ; machine learning ; drug discovery ; drug development ; Parkinson’s disease ; alpha-synuclein ; 6-OHDA ; Pink1 ; DJ1 ; exercise ; pharmacology ; pathology ; hypervigilance ; hyperreactivity ; exaggerated reactivity ; generalization ; PTSD ; depression ; heart rate ; Wistar ; 22-kHz calls ; 50-kHz calls ; affect ; aversion ; NOR ; reward ; working memory ; Y maze ; opioids ; fentanyl ; self-administration ; play ; food ; dam–pup interaction ; ethanol ; pup isolation ; rat pup ; 50 kHz vocalizations ; 22 kHz vocalizations ; amphetamine ; chemogenetics ; clozapine-n-oxide ; UMAP ; males ; females ; vocalizations ; fear extinction ; pain ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: pheochromocytoma ; paraganglioma ; genetics ; non-coding RNA ; malignancy ; biomarker ; treatment ; adaptive metabolism ; adrenal gland ; conn adenoma ; fatty acid metabolism ; ferroptosis ; hyperaldosteronism ; metabolic reprogramming ; β-oxidation ; PPARα ; tumor microenvironment ; Next Generation Sequencing ; hereditary cancer ; endocrine tumor syndrome ; KCNJ5 somatic mutation ; pulse wave velocity ; aldosterone-producing adenoma ; adrenalectomy ; propensity score matching ; arterial stiffness ; pheochromocytomas ; paragangliomas ; mutations ; susceptibility genes ; driver mutations ; hereditary ; germline ; somatic ; environment ; variants ; tumor suppressor genes ; metastatic ; RNAseq ; next generation sequencing ; adrenocortical carcinoma ; in silico analysis ; machine learning ; bioinformatic clustering ; biomarker prediction ; aldosterone producing adenoma ; ATP2B3 ; K416-F418delinsN mutation ; primary aldosteronism ; PPGL ; telomeres ; TERT ; ATRX ; NOP10 ; prognostic biomarker ; ALT ; phaeochromocytoma ; cancer ; mitochondrial complex II ; zebrafish ; therapy ; drug discovery ; redox balance pathway ; Vitamin C ; mitotane ; H295 strains ; microRNA ; aldosterone ; circulating ; adrenocortical ; transcriptomics ; epigenetics ; metabolomics ; epidemiology ; genetic analysis ; mortality ; surveillance ; TP53 R337H ; genetic testing ; adrenocortical tumor ; neonatal screening ; screening ; adenoma ; adrenal ; tissue ; artificial intelligence ; neural network ; n/a ; bic Book Industry Communication::M Medicine

Keywords: fibromyalgia ; physical functioning ; obesity ; pain catastrophizing ; pain acceptance ; chronic pain ; rehabilitation ; clinical psychology ; performance-based test ; dual-tasking ; cognitive function ; postural control ; older adults ; Parkinson disease ; personalized medicine ; clinical exercise ; exercise prescription ; boot camp ; physiotherapy ; compliance ; qualitative ; empowerment ; medication acceptability ; intentional nonadherence ; decision ; self esteem ; pharmacology ; rheumatology ; autoimmune ; adolescent ; nursing ; review literature ; sexuality ; virtual reality ; pain ; fatigue ; quality of life ; meta-analysis ; temporomandibular disorders ; surface electromyography ; aerobic exercise ; therapeutic exercise ; diabetes mellitus ; SGLT-2 inhibitors ; antidiabetic agents ; cardiovascular outcomes ; personalized therapy ; sleep ; chronic liver disease ; informal caregiver ; caregiver ; bibliometrics ; data analysis ; needs ; intervention ; patient-focused care ; aged ; disease prevention ; health promotion ; nursing education ; nursing students ; mental disorders ; mental illness ; social stigma ; students ; ageism ; stereotyping ; prejudice ; discrimination ; assessment ; aging ; stroke ; ischemia ; biomarkers ; mortality risk ; patient adherence ; glaucoma ; personalized care ; patient compliance ; child ; child abuse ; maltreatment ; neglect ; risk factors ; family ; caregivers ; child protective services ; advanced nursing practice ; rehabilitation nursing ; transitional care ; hospital discharge ; continuity of care ; hip fracture ; older person ; returning home ; safety ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: laminarin ; aging ; transient cerebral ischemia ; neuroprotection ; oxidative stress ; neuroinflammation ; marine-derived fungi ; anti-inflammation ; anti-neuroinflammation ; PTP1B ; marine biocompounds ; neurodegeneration ; Alzheimer’s disease ; Parkinson’s disease ; Bacillus sp. ; proteoglycan ; macrophages ; Padina boryana ; RAW 264.7 macrophages ; Nrf2/HO-1 ; MAPK ; NF-κB ; P. oceanica ; inflammation ; pain ; CD-1 mice ; bic Book Industry Communication::M Medicine

Keywords: bioequivalence ; Biopharmaceutics Classification System ; in vitro ; dissolution test ; pravastatin ; oral absorption ; in silico modeling ; GastroPlus ; Phoenix WinNonlin ; pharmacokinetics ; clinical studies ; ibuprofen ; manometry ; gastrointestinal ; mechanistic modeling ; PBPK ; PBBM ; disintegration ; dissolution ; enteric-coated ; ICH ; quality control ; regional intestinal permeability ; permeation enhancers ; absorption-modifying excipients ; oral peptide delivery ; intestinal perfusion ; pharmaceutical development ; controlled release drug product ; biopharmaceutics classification system ; drug solubility ; drug permeability ; location-dependent absorption ; segregated flow intestinal model (SFM) ; traditional model (TM) ; route-dependent intestinal metabolism ; first-pass effect ; drug-drug interactions ; DDI ; in vitro in vivo extrapolations ; IVIVE ; zero-order absorption ; first-order absorption ; combined zero- and first-order absorption ; transit compartment absorption model ; in situ perfusion ; microdevices ; shape ; mucoadhesion ; colon absorption ; nutrient digestion ; nutrient absorption ; gastrointestinal hormone ; postprandial glycaemia ; energy intake ; region of the gut ; obesity ; type 2 diabetes ; Franz–PAMPA ; BCS drugs ; biomimetic membrane ; Franz cell ; passive drug transport ; BCS class IV drugs ; segmental-dependent intestinal permeability ; intestinal absorption ; oral drug delivery ; biopharmaceutics ; physiologically-based pharmacokinetic (PBPK) modeling ; furosemide ; intestinal permeability ; human colon carcinoma cell layer (Caco-2) ; hierarchical support vector regression (HSVR) ; drug absorption ; drug solubility/dissolution ; regional/segmental-dependent permeability and absorption ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KND Manufacturing industries::KNDP Pharmaceutical industries

Keywords: patient-derived tumor xenograft (PDX) ; anti-cancer drug development ; immunodeficient mice ; precision medicine ; molecular profiling ; immunohistochemistry ; next-generation sequencing ; targeted therapy ; molecular oncology ; biomarkers ; molecular imaging ; non-small cell lung cancer ; proliferation ; cancer stem cells ; circulating tumour cells ; personalised treatment ; renal cell carcinoma ; clear cell ; VEGF ; immunotherapy ; PD-L1 ; immune checkpoint inhibitors ; immune checkpoint blockade ; tyrosine-kinase inhibitors ; integrin-linked kinase (ILK) ; ovarian cancer ; sgRNA ; gene expression ; microarray ; xenograft ; MTB ; cancer ; oncology practice ; community setting ; CGP ; pancreatic cancer ; FOLFIRINOX ; chemotherapy ; gender ; cholangiocarcinoma ; biliary tract cancer ; prognosis ; neutrophils ; BRCA1 ; BRCA2 ; PALB2 ; homologous recombination repair ; colorectal cancer ; heme oxygenase-1 ; endothelin-1 ; endothelin con-verting enzyme-1 ; bosentan ; precision oncology ; tumor-agnostic indications ; solid tumors ; tumor markers ; FDA-approved therapeutics ; n/a ; bic Book Industry Communication::M Medicine

Keywords: Medicine ; Nursing ; Education ; Health ; Veterinary ; Medical administration ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::J Society & social sciences::JN Education ; bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBD Medical profession::MBDC Medical ethics & professional conduct

Keywords: metalloproteinases ; calcification ; atherosclerosis ; multiplex assay ; coronary heart disease ; aspirin ; resistance ; non-sensitivity ; antiplatelet ; light transmission aggregometry ; Plateletworks® ; familial hypercholesterolemia ; targeted sequencing technologies ; multiplex ligation-dependent probe amplification ; LDLR ; APOB ; ABCG5 ; APOC3 ; LPL ; SREBF1 ; rare variants ; coronary atherosclerosis ; ischemic heart disease ; saturated fatty acids ; monounsaturated fatty acids ; polyunsaturated fatty acids ; oxidative stress ; superoxide dismutase ; catalase ; glutathione peroxidase ; cumulative LDL-C level ; prognosis ; DNA methylation ; epigenetic age ; myocardial infarction ; acute coronary syndrome ; population ; nested case-control ; HAPIEE project ; HAPIEE study ; atrial fibrillation ; arterial hypertension ; obesity ; diabetes mellitus ; aging ; determinants ; prevalence ; Russian population cohort ; Cox regression analysis ; adiponectin ; leptin ; interleukin-6 ; epicardial adipose tissue ; perivascular adipose tissue ; circulating biochemical markers ; coronary atherosclerosis presence and severity ; integrated biomarker (i-BIO) ; validation ; visual markers ; lipoprotein(a) ; immune cells blood count ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJD Cardiovascular medicine

Keywords: bic Book Industry Communication::M Medicine

Keywords: oncolytic viruses ; melanoma ; immunotherapy ; checkpoint inhibitors ; combinatory therapy ; reovirus ; oncolytic virus ; adenovirus ; oncolytic ; virotherapy ; targeting ; immunogenic cell death ; αvβ6 integrin ; oncolytic adenovirus ; cancer immunotherapy ; multi-stage ; immunostimulatory ; arming ; HSV-1 ; clinical trials ; newcastle disease virus ; NDV ; cancer ; immune checkpoint inhibitor ; PD-1 ; PD-L1 ; CTLA-4 ; type I interferon ; herpes simplex virus ; retargeted virus ; tropism retargeting ; tumor ; checkpoint inhibitor ; vaccination ; antigen-agnostic vaccination ; HER2 ; parvovirus ; tumor microenvironment ; combination therapy ; glioblastoma ; pancreatic cancer ; colorectal cancer ; measles virus ; vector engineering ; immune checkpoint blockade ; antitumor immune response ; delivery ; genetic modification ; biomarkers ; personalized oncolyticvirotherapy ; class I HLA ; immunosurveillance ; immunoediting ; oncogenic signaling ; RAS ; DNA methyltransferase inhibitor (DNMTi) ; viral mimicry ; epigenetic silencing ; adoptive T cell therapy ; CAR T cell ; pancreatic ductal adenocarcinoma ; vesicular stomatitis virus ; small molecule ; cancer immune therapy ; cancer therapy ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine

Keywords: renal cell carcinoma ; autophagy ; hydroxychloroquine ; chloroquine ; ROC-325 ; cysteine cathepsins ; cysteine cathepsin inhibitors ; lysosome ; renal cancer ; metastatic renal cell carcinoma ; immune-based combination therapies ; network meta-analysis ; PD-L1 ; predictive ; biomarker ; treatment ; TKIs ; mRCC ; biomarkers ; soluble factors ; immunotherapy ; renal cell carcinoma (RCC) ; sunitib resistance ; artesunate (ART) ; Traditional Chinese Medicine (TCM) ; growth inhibition ; ferroptosis ; reactive oxygen species (ROS) ; clear cell renal cell carcinoma ; ccRCC ; RCC ; kidney cancer ; evolution ; evolutionary trajectory ; metastatic ; second line therapy ; renal cell cancer ; immune checkpoint inhibitors ; tyrosine kinase inhibitors ; individualization ; genomic signature ; transcriptomic analysis ; bic Book Industry Communication::M Medicine

Keywords: diagnostic method ; severity of disturbances ; rheology ; diabetes mellitus ; erythrocyte ; dielectrophoresis ; anemia of chronic disease ; iron deficiency anemia ; hyperlipidemia ; inflammation ; C-reactive protein ; tumor necrosis factor-α ; erythrocyte sedimentation rate ; osteoporosis ; fracture ; menopause ; population ; chronic non-communicable diseases ; risk factors ; early IHD ; abdominal obesity ; blood cytokines/chemokines complex ; multiplex assay ; Flt3 ligand ; GM-CSF ; MCP-1 ; IL-4 ; maturity onset diabetes of the young type 14 ; APPL1 ; single-nucleotide variant ; Firmicutes ; Bacteroidetes ; gut microbiota ; bile microbiota ; gallstone patients ; maturity onset diabetes of the young ; MODY ; multiplex ligation-dependent probe amplification ; next-generation sequencing ; GCK ; HNF1A ; HNF4A ; HNF1B ; obesity ; BMI ; blood tests ; proteomics ; mass spectrometry ; norepinephrine concentration in the hypothalamus ; heart mass ; QTL analysis ; SNPs ; ISIAH hypertensive rat strain ; risk factor ; diabetes risk scale ; diabetes risk model ; type 1 diabetes mellitus ; type 2 diabetes mellitus ; proton spectroscopy ; hippocampus ; cognitive dysfunction ; n/a ; bic Book Industry Communication::M Medicine

Keywords: perfusion estimation ; temperature monitoring ; conductivity reconstruction ; systems medicine ; immune system in silico ; perceptron ; antigen pattern ; danger signal ; fractionation ; immune response ; head and neck cancer ; hyperthermia ; reirradiation ; treatment outcome ; hyperthermia treatment planning ; adaptive planning ; temperature optimization ; low-middle-income group countries ; cancer ; radiotherapy ; chemotherapy ; recurrent breast cancers ; cervical cancer ; head and neck cancers ; cost-effective ; meta-analysis ; intensity-modulated radiotherapy ; prostate cancer ; thermal dose ; thermometric parameters ; preclinical data ; clinical evidence ; modulated electro-hyperthermia ; abscopal effect ; locally advanced cervical cancer ; resource-constrained setting ; radiosensitiser ; rectal cancer ; chemoradiotherapy ; tumour control ; loco-regional hyperthermia ; oncology ; cellular selection ; bioelectromagnetics ; complexity ; immune-effects ; moderate hyperthermia ; deep hyperthermia ; radiative hyperthermia ; patterns of care ; reimbursement ; regional hyperthermia ; neoadjuvant chemoradiation ; survival ; induced ; brachytherapy ; prostatic neoplasms ; interstitial hyperthermia ; treatment plan optimization ; prostate ; thermoradiotherapy ; linear quadratic model ; biological modeling ; thermal dosimetry ; hypoxia ; radiation therapy ; reoxygenation ; perfusion ; oxygen consumption rate ; local tumor control ; biomarker ; immune phenotype ; hyperthermia treatment sequence ; breast cancer ; immune checkpoint molecules ; dendritic cell activation ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology

Keywords: risk perception ; China as an international tourism destination ; anticipated emotions ; destination attachment ; post-pandemic ; COVID-19 ; customer behavior ; psychological process ; live-streaming shopping apps ; stimulus-organism-response framework ; Unified Theory of Acceptance and Use of Technology 2 ; Flow Theory ; gender ; age ; SARS-CoV-2 ; environmental contamination ; air samples ; surface samples ; bottom trawling ; COVID-19 pandemic lockdown ; environmental impacts ; macrobenthic fauna ; tidal channels ; central Mediterranean Sea ; ethnopharmacology ; skin diseases ; cosmetics ; Lithuania ; global environment ; solid waste ; air quality ; transport ; airborne ; CO2 ; collective transport ; tramway ; filtration ; infectious diseases ; epidemiology ; public health ; elementary teacher ; junior high school teacher ; psychological change ; physical changes ; urban mobility ; parking demand ; IoT parking sensors ; explanatory data analysis ; parking policies ; vaccinations ; pharmacist ; KAP ; infection control ; burnout ; COVID-19 pandemic ; postnatal care ; psychological distress ; psychosocial support ; health-seeking behavior ; appendicitis ; surgical care ; metrology ; data analysis ; atmospheric environment ; pollution ; coronavirus ; comorbidity ; spatial analysis ; logistic regression ; ROC curve ; freight transport ; air freight ; sea shipping ; road transport ; recovery measures ; strategies ; public trust ; perceived societal fairness ; mental health ; air pollution ; PM2.5 concentration ; gym sports ; spatial econometric model ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBN Public health & preventive medicine::MBNS Epidemiology & medical statistics

Keywords: intraocular pressure ; serum calcium ; female ; ab interno trabeculotomy ; glaucoma ; incision in the Schlemm’s canal in degrees ; post-surgical complication ; neuroretinal rim reversal ; Bruch’s membrane opening-minimum rim width ; trabeculectomy ; refractive error ; neuroretina ; myopia ; intraocular pressure (IOP) ; tonometry ; Goldmann applanation tonometer (GAT) ; central corneal thickness (CCT) ; ocular hypertension ; higher-order aberrations ; Kahook Dual Blade ; age ; central corneal thickness ; Goldmann Applanation tonometer ; non-contact tonometer ; rebound tonometer ; iCare ; open angle glaucoma (OAG) ; Schlemm’s canal viscodilation ; OMNI viscosurgical system ; minimally invasive glaucoma surgeries (MIGS) ; trabeculotomy ; cataract extraction ; aqueous humor ; GDF15 ; serum ; intravitreal injection ; anti-VEGF agents ; trabecular meshwork ; Matrigel ; 3D culture ; outflow ; cytoskeleton ; rho-kinase inhibitor ; prostaglandin analog ; childhood glaucoma ; aphakia ; pseudophakia ; cataract surgery ; lensectomy ; management (or therapy) ; glaucoma drainage device ; cyclodestruction ; corneal biomechanics ; ocular response analyzer ; ORA ; corneal hysteresis ; non-penetrating deep sclerectomy ; Esnoper V-2000 implant ; glucocorticoids ; safety profile ; intranasal administration ; inhaled administration ; systemic administration ; steroid response ; canaloplasty ; non-perforating surgical procedures ; pseudoexfoliation glaucoma (PEXG) ; Schlemm’s canal ; phase-sensitive optical coherent tomography ; pulsatile motion ; IOP fluctuation ; primary open-angle glaucoma ; intraocular pressure measurement ; iCare tonometry ; Perkins tonometry ; standardized anaesthesia ; corneal thickness ; progression ; risk stratification ; XEN GelStent ; corneal resistance factor ; open-angle glaucoma ; n/a ; laser treatment ; dropless treatment ; thyroid-associated ophthalmopathy ; extraocular muscle ; magnetic resonance imaging ; T2 relaxation time ; bic Book Industry Communication::M Medicine

Keywords: Wnt signaling ; synovial sarcoma ; TNIK ; NCB-0846 ; MYC ; hepatitis B virus ; HBV ; cancer ; liver cancer ; β-catenin ; TCF/LEF ; pancreatic cancer ; pancreatic stellate cells ; CBP ; p300 ; pancreatitis ; fibrosis ; just-right signaling ; APC ; colorectal cancer ; RNA-binding proteins ; Musashi ; drug discovery ; Notch signaling ; cancer therapy ; fungi secondary metabolite derivative ; microenvironment ; Wnt ; AML ; drug target ; signaling ; colorectal ; porcupine ; R-spondin ; serrated ; immunotherapy ; wnt ; vitamin D ; colon cancer ; L1 ; Wnt target genes ; cell adhesion ; NF-κB ; invasion and metastasis ; cancer stem cells ; EMT ; Lgr5 ; Wnt/beta-catenin signaling ; angiogenesis ; anti-angiogenic therapy ; gastrointestinal cancers ; therapeutic targeting of Wnt signaling ; β-catenin paradox ; molecular targeting ; urothelial cancer ; immune checkpoint inhibitor ; immunotherapy resistance ; IBD ; colitis ; β-catenin mutations ; tumor metabolism ; tumor immunology ; molecular therapeutics ; precision medicine ; astrocytic brain tumors ; DKKs ; GSK3β ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: metastatic breast cancer ; breast surgery ; immune system ; metabolic derangements ; precision medicine ; integrated therapies ; advanced breast cancer ; mTOR inhibitor ; CDK4/6 inhibitor ; endocrine resistance ; breast cancer ; pregnancy ; chemotherapy ; tailoring ; personalization ; DataMart ; real world data ; predictive model ; healthcare ; breast-conserving surgery ; non-palpable breast lesions ; image-guided localization ; preoperative breast localization ; breast ultrasound ; large database ; standardized data collection ; networks ; nipple-sparing mastectomy ; immediate breast reconstruction ; acellular dermal matrix (ADM) ; aesthetic and oncological outcomes ; quality of life ; rare breast cancer ; osteoclast-like giant cells ; gene profiling ; Oncotype Dx ; adjuvant treatment ; neoadjuvant chemotherapy ; sentinel lymph node ; systemic treatment ; locally advanced breast cancer ; mini-invasive treatment ; liver metastases ; hepatic surgery ; personalized medicine ; sarcopenia ; physical performance ; frailty ; older cancer patients ; clinical trial ; patient enrollment ; artificial intelligence ; machine learning ; lung cancer ; oncology ; web app ; conventional CT and CT angiography ; DIEP flap planning ; multidisciplinary treatment ; evidence-based medicine ; personalized treatment ; oncological outcomes ; patient quality of life ; normal breast ; breast pathology ; hormone receptor ; hormone expression ; lymphedema ; lymphaticovenous anastomosis ; vascularized lymph node transfer ; lymphatic microsurgery ; radiotherapy ; oligometastatic breast cancer ; locoregional therapy ; CDK4/6 inhibitors ; multidisciplinary ; AMH ; ovarian reserve ; pregnancy desire ; subtypes breast cancer ; miRNAs ; breast cancer treatment ; next-generation-sequencing ; target therapy ; old age ; survival ; vitamin D ; ductal breast cancer ; in situ breast cancer ; lobular breast cancer ; histology ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: Anorexia nervosa ; treatment contracts ; weight gain ; inpatient treatment ; survey ; accelerometry ; eating disorders ; motor restlessness ; physical inactivity ; anorexia nervosa ; cognitive behaviour therapy ; manualised treatment ; modules ; worksheets ; guidelines ; evidenced-based ; treatment ; emotion regulation ; males ; drug-treatment ; pharmacotherapy ; medication ; nutrition ; comorbidity ; complication ; functional magnetic resonance imaging ; disorder-specific stimuli ; narrative review ; immune system ; inflammation ; cytokines ; bic Book Industry Communication::M Medicine

Keywords: 70-kDa heat shock proteins ; gingival crevicular fluid ; heat shock protein ; periodontitis ; periodontal disease ; diabetes ; diabetic retinopathy ; bleeding on probing ; probing pocket depth ; fasting blood sugar ; carotid artery calcification ; alveolar bone loss ; computed tomography ; panoramic radiographs ; aspiration pneumonia ; chronic periodontitis ; Porphyromonas gingivalis ; proinflammatory cytokines ; TLR2 ; epidemiological index ; item response theory ; oral examination ; diagnosis ; Mfa1 ; Toll-like receptors ; gingival fibroblast ; azithromycin ; human gingival fibroblast ; human periodontal ligament fibroblast ; IL-6 ; IL-8 ; MMP-1 ; MMP-2 ; chewing ability ; infection ; inflammation ; periodontal medicine ; Gan-Lu-Yin ; herbal medicine ; osteoclastogenesis ; periodontal diseases ; periodontal pocket ; health status indicators ; periodontal inflamed surface area (PISA) ; rheumatoid arthritis ; tocilizumab ; periodontal inflamed surface area ; periodontal pathogen ; mixed effect modeling ; follow-up study ; Low reactive Level Laser Therapy (LLLT) ; human gingival fibroblasts (HGF) ; microarray ; differentially gene expression (DEGs) ; gene ontology ; biological processes (BP) ; protein–protein interaction (PPI) ; bic Book Industry Communication::M Medicine

Keywords: highly pathogenic avian influenza virus ; H5N6 (clade 2.3.4.4) ; human sera ; SARS-CoV-2 ; COVID-19 ; full proteome ; peptide microarrays ; glycan microarrays ; seroprevalence ; ELISA ; neutralization assay ; viral persistence ; serum antibody ; neutralization efficacy ; cytokine profile ; neutralising antibodies ; filoviruses ; ebolavirus ; post-vaccination ; post-infection ; monoclonal antibodies ; longitudinal antibody response ; antibody specificity ; recombinant proteins ; virus neutralization ; coronavirus disease 2019 ; Guangdong ; China ; antibody ; varicella–zoster virus (VZV) ; chemiluminescent immunoassay (CLIA) ; IgA ; IgG ; IgM ; diagnostic test ; antibody therapeutic ; cryo-EM ; filovirus ; marburgvirus ; structural biology ; X-ray crystallography ; n/a ; bic Book Industry Communication::M Medicine

Keywords: VRE ; GIT ; hemato-oncological patients ; clonality ; antibiotic stewardship ; resistance ; consumption of antibiotics ; clonal spread ; Enterococcus faecium ; Enterococcus faecalis ; linezolid resistance ; 23S rRNA ; optrA ; carbapenem-resistant Klebsiella pneumoniae ; carbapenem-resistant Acinetobacter baumannii ; N-acetylcysteine ; septic shock ; critically ill patients ; newborn ; infection ; bacteria ; antibiotic therapy ; hops ; C. difficile ; rat model ; Staphylococcus aureus ; MRSA ; spa typing ; MLST ; SCCmec typing ; clonal analysis ; epidemiology ; cancer patients ; duration of treatment ; colistin ; propensity score analysis ; multidrug-resistant Acinetobacter baumannii ; urinary tract infections ; UTIs ; MDR ; Escherichia coli ; Klebsiella ; uropathogens ; AMR ; antibiotic resistance ; ESBL-producing Klebsiella pneumoniae ; urinary tract infection ; clinical impact ; economic impact ; ventilator-associated pneumonia ; Klebsiella spp. ; Escherichia spp. ; pulsed-field gel electrophoresis (PFGE) ; endogenous infection ; methicillin-resistant ; porcine model ; methicillin-resistant Staphylococcus aureus (MRSA) ; long term care facilities (LTCF) ; multidrug resistance (MDR) ; enterobacterial repetitive intergenic consensus-polymerase chain reaction (ERIC-PCR) ; ESBL ; PCR ; primer ; antimicrobial resistance ; infection prevention and control ; antimicrobial stewardship ; hospital ; cluster analysis ; principal component analysis ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MB Medicine: general issues::MBN Public health & preventive medicine::MBNS Epidemiology & medical statistics

Keywords: fever ; FeverApp ; ecological momentary assessment ; user behavior ; sociodemographic characteristics ; registry ; guidelines ; feasibility ; usability ; routine health information system ; health management information system ; health system performance ; machine learning ; digital health ; registry analysis ; ClinicalTrials.gov ; device regulation ; new information technology ; Technology Acceptance Model (TAM) ; institution ; institutionalism ; digital informatics ; human–computer interaction ; personal health informatics ; consumer health data ; consumer health information ; self-tracking ; quantified self ; mHealth apps ; telemonitoring ; telemedicine ; telecardiology ; cardiology ; wearable ; sensors ; consumer health devices ; cardiovascular disease ; heart failure ; atrial fibrillation ; mental health ; psychiatry ; psychiatric record ; psychiatric notes ; patient accessible electronic health record ; PAEHR ; open notes ; policies ; COVID-19 ; technology acceptance ; user survey ; wearable health monitor ; ECG patch ; personal electronic health records ; technology adoption ; endogenous motivations ; health information privacy concern ; mixed-methods ; ePA ; online review helpfulness ; signaling theory ; sentiment analysis ; physician rating websites ; consumer decision-making ; health information technology ; information exchange ; hospital ; market ; bic Book Industry Communication::M Medicine

Keywords: Moorena bouillonii ; marine natural products ; chemogeography ; metabolomics ; natural products ; dereplication ; antibiotics ; marine sponges ; plant pathogen ; cyclodepsipeptides ; marine Actinobacteria ; Streptomyces spp. ; antibiotic ; sea cucumber ; HCV ; Actinobacteria ; marine ; Polar ; genomics ; specialised metabolites ; chitin ; chitinase ; chitin degradation machinery ; Pseudoalteromonas ; secondary metabolites ; bacterial natural products ; mass spectrometry ; genome mining ; paired omics ; keratinases ; keratinolytic proteases ; marine-derived Streptomyces ; genomic comparison ; cyanobacteria ; symbionts ; comparative genomics ; biosynthetic gene clusters ; Indonesia ; biodiversity ; novel antibiotics ; drug screening ; bioactivity ; gene cluster networking ; GNPS ; enterococci ; genome-wide analysis ; bacteriocins ; probiotics ; wild marine species ; Neolyngbya ; anticancer ; drug discovery ; South China Sea ; wenchangamide ; Moorea producens ; CuSO4·5H2O assisted ; differential gDNA isolation ; filamentous bacteria ; micrococcin P1 and P2 ; stalked diatoms ; bic Book Industry Communication::M Medicine

Keywords: photoacoustic microscopy ; ultrasonic transducer ; optical-resolution photoacoustic microscopy ; transparent ultrasound transducer ; ultrasound stimulation ; photoacoustic ; LED ; clinic ; optical imaging ; tomography ; ultrasound ; small animal ; liver ; fibrosis ; optoacoustic ; spectral imaging ; blind source separation ; unsupervised unmixing ; photoacoustic imaging ; 3-D printed photoacoustic probe holder ; light delivery optimization ; LED divergence ; illumination scheme ; in vivo ; mouse ; Monte Carlo ; linear array ; tumor imaging ; LED-based photoacoustic imaging ; hair follicles ; FUE ; FUT ; photoacoustic computed tomography ; light-emitting diodes ; laser diodes ; oxygen saturation imaging ; photoacoustics ; fluence compensation ; hypoxia ; deep tissue imaging ; hemangioma ; laser ; light-emitting diodes (LED) ; mobile health ; peripheral arterial disease ; stroke ; vascular malformations ; signal enhancement ; pre-illumination ; photo-thermal effect ; heat capacity ; remote sensing ; endoscopy ; speckle ; n/a ; bic Book Industry Communication::M Medicine

Keywords: Materia medica; Russia; history ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::H Humanities::HB History

Keywords: early food preferences ; feeding strategy ; dietary habits ; disease-related malnutrition ; educational intervention ; nutritional intervention ; obesity in childhood ; bic Book Industry Communication::M Medicine

Keywords: curcumin ; high glucose ; osteogenesis ; bone formation ; diabetic osteoporosis ; cell survival ; cell migration assay ; calcium silicate-based cements ; calcium nodule formation ; bone substitute ; sinus floor augmentation ; maxillary tuberosity ; blood clotting ; dental implants ; hydrophilicity ; titanium ; ultraviolet rays ; bone morphogenetic protein 4 ; cell differentiation ; cellular spheroids ; gingiva osteogenesis ; stem cells ; titanium mesh ; bone graft ; guided bone regeneration ; ridge augmentation ; surface topography ; bacterial adhesion ; biomimetics ; soft lithography ; surface modification ; anti-bacterial agents ; calcium phosphate ; guided tissue regeneration ; membranes ; calcium sulfate ; dental implant ; sinus lift ; bioactive materials ; bioactive ceramic ; bioactive glass ; nanohydroxyapatite ; sol-gel process ; bic Book Industry Communication::M Medicine

Keywords: multiple myeloma ; venous thromboembolism ; risk assessment models ; thromboprophylaxis ; direct oral anticoagulants ; cancer-associated venous thromboembolism ; thrombosis ; pulmonary embolism ; neoplasms ; anticoagulants ; coumarins ; low molecular weight heparins ; cancer ; endogenous heparin ; heparanase ; heparan sulfate ; hospice ; palliative care units ; low molecular weight heparin ; deep vein thrombosis ; cancer associated thrombosis ; VTE ; malignancy ; direct oral anticoagulant ; pancreatic cancer ; low-molecular weight heparin ; survival ; coagulation activation ; locally advanced breast cancer ; prognostic model ; pCR ; treatment ; prophylaxis ; DOAC ; simultaneous care ; integrated care ; lymphoma ; Non-Hodgkin lymphoma ; Hodgkin lymphoma ; risk factors ; molecular subtype ; arterial thrombosis ; ALK ; ROS1 ; KRAS ; chemotherapy ; low-molecular-weight heparin (LMWH) ; VKA ; UFH ; DOACs ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders::MJCL Oncology

Keywords: Chagas disease ; immunoassays ; chimeric proteins ; stability ; biodegradable materials ; metal-organic framework ; metal ion nodes ; multimode imaging ; theranostic nano-platforms ; MCF-7 cells ; electrochemistry ; 2-D materials ; signal amplification ; DNA assembly ; bio-responsive fluorescent complexes ; shRNA delivery ; LncRNA MALAT1 ; cancer cells bioimaging ; therapeutics ; autophagy ; biosensor ; microfluidics ; organ-on-a-chip ; lung model ; lung-on-a-chip ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: autism spectrum disorder ; infants ; frontal EEG alpha asymmetry ; early detection ; autism spectrum disorders ; toddlers ; eye tracking ; joint attention ; longitudinal ; regression ; cytokines ; PAI-1 ; neuroinflammation ; gastrointestinal ; autism ; literature review ; comorbidity ; early intervention ; early intensive behavioral intervention ; behavioral intervention ; First Year Inventory ; early screening ; risk ; cross-cultural generalisability ; validity ; preschool teachers ; self-efficacy ; knowledge ; belief ; skills ; identify ; autism spectrum disorder (ASD) ; level 1 and level 2 screening tools ; systematic review ; COSMIN ; PRISMA ; screening ; infection ; prion ; meta-analysis ; motion analysis ; video signal processing ; neurodevelopmental disorders ; infant screening ; n/a ; developmental language disorder ; semantic features ; word learning ; central coherence ; biomarker ; p-cresol ; mouse social behavior ; dopamine ; ASD ; vision ; proprioception ; self-motion ; immersive virtual reality ; IVR ; HMD ; technology ; persuasive text writing ; perspective-taking ; adolescence ; intervention ; sign language ; imitation ; cognition ; language acquisition ; prevalence estimate ; predictors ; surveillance review ; Autism Spectrum Disorder (ASD) ; early intensive intervention ; developmental trajectories ; moderators and mediators of intervention. ; psychosis ; schizophrenia ; psychopathology ; AQ ; accuracy ; attention to detail ; self-awareness ; insight ; preconception risk factor ; Gilles de la Tourette ; obsession ; compulsion ; social behavior ; social impairment ; sensory profile ; sensory responsiveness ; feeding problems ; short sensory profile (SSP) ; sensory experience questionnaire (SEQ) ; coronavirus ; 2019-nCoV ; neurodevelopment ; child and adolescent psychiatry ; mental health prevention ; Asperger syndrome ; adults ; cerebrospinal fluid ; antibodies ; blood–brain barrier ; GAD65 ; Early Start Denver Model ; high-risk infants ; motor development ; high-functioning autism ; language ; experience ; communication ; autonomic nervous system ; wearable technologies ; EEG ; theory of mind ; adults and adolescents ; human figure drawings ; Draw-a-Man ; drawings maturity ; social perception ; ERP ; reward response ; RewP ; sensitization ; social skills intervention ; PEERS® ; adulthood ; diagnosis ; autistic traits ; action observation ; action prediction ; context ; priors ; hypothalamus ; amygdala ; oxytocin ; social cognition ; social interaction ; affiliative behavior ; neuroimaging ; COVID-19 ; challenging behavior ; dental care ; oral health ; medical procedures ; ICT ; wearable sensors ; migration ; Europe ; health system ; autism in adulthood ; intellectual disability ; regressive autism ; epilepsy ; challenging behaviors ; empathy ; executive functions ; attention deficit and hyperactivity disorder ; disruptive behavior disorders ; alexithymia ; anxiety ; depression ; TAS-20 ; TSIA ; parents ; broader autism phenotype ; autistic-like features ; social-cognitive development ; stereotypical behaviors ; visual impairment ; language profiles ; grammatical comprehension ; cannabinoids ; cannabidiol ; cannabidivarin ; THC ; problem behaviors ; sleep ; hyperactivity ; side effects ; motor performance skills ; Gulf ; BOT-2 ; machine learning ; employment ; telehealth ; ABA ; RCT ; cortisol ; group activity ; stress ; art ; assessment ; sensorimotor integration ; postural balance ; false positive report probability (FPRP) ; Bayesian false-discovery probability (BFDP) ; Genome-Wide Association Studies (GWAS) ; microbiome ; metabolomics ; study design ; biomarker discovery ; precise medicine ; bipolar disorder ; suicidal ideation ; suicidal attempts ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: consumer behavior ; electroencephalogram (EEG) biosensor ; attention and meditation ; brain computer interface ; Brain-Computer Interface (BCI) ; Steady-State Visual Evoked Potential (SSVEP) ; artefact removal ; Individual Alpha Peak ; movement artefact ; Electroencephalography (EEG) ; classification ; emotion ; facial nerve paralysis ; LASSO ; MEG ; passive brain–computer interface (pBCI) ; EEG headsets ; daily life applications ; In-ear EEG ; echo state network (ESN) ; attention monitoring ; vigilance task ; brain-computer interface (BCI) ; electroencephalography (EEG) ; emotion recognition ; independent component analysis (ICA) ; regression ; stroke ; electroencephalogram (EEG) ; bispectrum ; multimodal fusion ; brain–computer interface (BCI) ; affective computing ; EEG-based emotion detection ; spiking neural network ; NeuCube ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: hormones ; LH ; testosterone ; cortisol ; insulin ; athletes ; body alignment ; static balance ; dynamic balance ; basketball ; mouthguard ; microalgae ; soccer ; ergogenic ; ventilatory threshold ; racket sports ; technique ; performance analysis ; tactics ; sport ; vision ; performance ; racquet sports ; professional sport ; game actions ; trace mineral ; runners ; overuse injury ; biomechanics ; home-based exercise ; sustainable development ; SWOT-AHP ; physical activities ; public health ; COVID-19 ; intelligent sports ; iliopsoas ; rectus femoris ; mobility ; flexibility ; tennis ; movement ; physical tests ; athletic performance ; youth sports ; females ; football ; NIRS ; muscle oxygen saturation ; workload ; physiological adaptations ; fatigue and sport performance ; technical indicators ; tactical indicators ; paddle tennis ; trail running ; jump ; neuromuscular ; hydration ; sport vision ; social media ; social network analysis ; Altmetric ; padel ; sports competition ; myokines ; BDNF ; leukemia inhibitory factor ; irisin ; n/a ; running ; economic factors ; sport events ; expertise ; inertial sensors ; kinematic analysis ; perception-action coupling ; visual fixation ; pedaling rate ; pedaling frequency ; fatigability ; EMG ; strength ; water sport ; endurance ; origin ; nationality ; bic Book Industry Communication::M Medicine

Keywords: coumarins ; Lycium ; metabolomic ; HPLC-MS ; orbitrap ; secondary metabolites ; endemic plants ; olive leaves ; supercritical fluid extraction ; antioxidants ; hyperuricemia ; plant-based functional food ; xanthine oxidase ; adenosine deaminase ; uric acid transporter ; bioactive compound ; Piper pseudoarboreum ; bioassay-guided fractionation ; leishmanicidal activity ; alkamides ; (E)-piplartine ; Wedelia chinensis ; organic farming ; phytotoxic substances ; vanillic acid ; gallic acid ; Origanum subspecies ; morphological traits ; glandular trichomes ; essential oil composition ; rosmarinic acid ; sensory evaluation ; colored potato tubers ; total phenols ; anthocyanins ; saccharides ; nutrition ; microelements ; plants ; fungi ; food supplements ; cardiovascular diseases ; neurodegenerative diseases ; Alzheimer’s disease ; metabolic syndrome ; apocarotenoid ; caffeic acid derivative ; flavonoid ; Lactuca sativa ; lignan ; megastigmane ; sesquiterpene lactone ; 1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid ; black chokeberry ; anthocyanin ; simulated moving bed ; antioxidant activity ; neuroprotection ; Artemisia ; clinical trials ; health effects ; adverse effects ; anticancer ; antiparasitic ; artemisinin ; santonin ; achillin ; tehranolide ; Aglaomorpha quercifolia ; GC-MS profile ; rhizome ; leaves ; n-hexane extract ; fatty acids ; terpenoids ; linolenic acid ; hop-16-ene ; cardiac glycosides ; secondary plant metabolites ; natural product isolation ; hyrcanoside ; deglucohyrcanoside ; ouabain ; cymarin ; digitoxin ; anticancer activity ; Na+/K+-ATPase inhibitors ; corn salad ; leafy vegetables ; phytochemicals ; liquid chromatography ; mass spectrometry ; celastrol ; Celastraceae ; antimicrobial activity ; mechanism of action ; Bacillus subtilis ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: cystinosis ; cysteamine ; bone ; osteoclast ; genotype ; CD34+ hematopoietic stem and progenitor cells ; gene therapy ; pre-clinical studies ; investigational new drug application ; clinical trial ; disulfiram ; mice ; zebrafish ; fertility ; azoospermia ; hypogonadism ; histopathology ; mouse model ; lysosomal storage disease ; cell and animal models ; infantile nephropathic cystinosis ; bone-muscle wasting ; fibroblast growth factor 23 ; osteoclasts ; sclerostin ; leptin ; fractures ; nephropathic cystinosis ; hollow fiber membrane ; 3-dimensional models ; autophagy ; macrophages ; inflammasome ; proximal tubular cells ; endocytosis ; apoptosis ; chitotriosidase ; interleukins ; galectin-3 ; novel therapies ; endolysosome ; epithelial cell differentiation ; homeostasis ; lysosomal storage diseases ; mitochondrial distress ; kidney proximal tubule ; programmed cell death ; central nervous system ; cortical atrophy ; arterial spin labelling ; cystine blood level ; lysosomal storage disorder ; history ; treatment strategies for cystinosis ; newborn screening ; clinical course ; CTNS-pathogenic variants ; newborn screening for cystinosis ; kidney progenitors ; cell model ; biomarkers ; cystine ; kidney ; therapeutic monitoring ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: angiogenesis ; vessel maturity ; vessel permeability ; hemorrhage ; atherosclerosis ; two-photon intravital microscopy ; transforming growth factor-β ; endoglin ; neovascularization ; tissue repair ; myocardial infarction ; hind limb ischemia ; critical limb ischemia ; arteriogenesis ; cell therapy ; secretomes ; AP-1 transcription factors ; JunB ; tip cell specification ; vascular development ; neurovascular interactions ; peripheral arterial disease ; biomarkers ; inflammation ; coagulation ; extracellular vesicles ; microRNAs ; machine learning ; gene therapy ; stem cells ; clinical trials ; bioengineering ; gene expression ; non-viral vectors ; 2A-peptides ; growth factors ; tube formation ; VEGF ; FGF2 ; cytokines ; animal model ; Matrigel plug assay ; cold-inducible RNA-binding protein ; extracellular cold-inducible RNA-binding protein ; CIRP ; eCIRP ; neutrophil extracellular traps ; NETs ; macrophage polarization ; apoptosis ; ischemia ; vascular smooth muscle cell ; phenotypic switch ; collateral arteries ; C57BL/6J mice ; SV-129 mice ; leukocytes ; macrophages ; neutrophils ; C57BL6 ; 129S1/Sv ; CIRBP ; 14q32 microRNAs ; HUVECs ; n/a ; bic Book Industry Communication::M Medicine

Keywords: equine coronavirus ; horse ; enteric disease ; ECoV ; seroprevalence ; equine ; viruses ; loop-mediated isothermal amplification ; insulated isothermal polymerase chain reaction ; field-deployable ; point-of-care testing ; Huculs ; viral status ; immunological status ; equine viral diseases ; EHV-1 ; EHV-4 ; ELISA ; VNT ; Morocco ; equine parvoviruses ; equine parvovirus hepatitis ; equine parvovirus CSF ; equine copivirus ; nasal fluid ; blood ; qPCR ; sick equids ; healthy horses ; gammaherpesvirus ; horses ; respiratory disease ; equine herpesvirus 1, -2, -4, -5 ; equine influenza ; quantitative PCR ; equine encephalosis virus ; EEV ; epidemiology ; clinical disease ; control ; Culicoides ; SARS-CoV-2 ; nasal secretions ; n/a ; bic Book Industry Communication::M Medicine

Keywords: Chronic conditions, Comorbidity, RWE, Multimorbidity clusters ; bic Book Industry Communication::M Medicine

Keywords: partial nephrectomy ; single site surgery ; sutureless ; CEUS ; contrast-enhanced ultrasound ; renal ultrasound ; image quality ; small renal mass (3–5) ; kidney stones ; metabolic syndrome ; urolithiasis ; nephrolithiasis ; kidney calculi ; diabetes mellitus ; acute kidney injury ; percutaneous nephrolithotomy ; urology ; artificial intelligence ; machine learning ; urinary incontinence ; kidney stone disease ; fertility ; reproductive urology ; renal cell carcinoma ; hydronephrosis ; urinary reflux ; endourology ; pediatric urology ; prostate cancer ; bladder cancer ; nephrostomy ; quality of life ; survival ; decision making ; ureteroscopy ; laser ; RIRS ; Moses ; holmium ; mineral water ; mineral composition ; drinking water ; still water ; sparkling water ; Ho:YAG laser ; thulium fiber laser ; laser fiber ; lithotripsy ; chronic prostatitis ; chronic pelvic pain syndrome ; extracorporeal shockwave therapy ; ESWT ; NIH-CPSI ; EHS ; IIEF-5 ; QoL ; urosepsis ; laser lithotripsy ; predictor factors ; PCNL ; renal tumour ; AI ; TFL ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MN Surgery

Keywords: chronology; precision; biomedicine; biomedical ; bic Book Industry Communication::M Medicine

Keywords: Autism Spectrum Disorders (ASD) ; childhood apraxia of speech ; children ; Magnetic Resonance Imaging (MRI) ; neuroanatomy ; FreeSurfer ; affective disorder ; perinatal period ; fatherhood ; prevention ; gender ; screening ; TMAU ; psychiatric disorders ; microbiota ; Attentional Boost Effect ; bipolar disorder ; euthymic patients ; recognition memory ; genetic variants ; criminal behaviour ; frequency data ; gambling disorder ; attachment ; adolescence ; friend and family interview ; forgetting ; neurotransmitter system ; psychopathologies ; mentalization ; self-report measure ; multilevel model ; integration ; assessment ; COVID-19 ; young adults ; social isolation ; psychological distress ; emotional eating ; emotional dysregulation ; depression ; nomogram ; patient health questionnaire ; multiple risk factors ; epidemiological survey ; high-risk group ; affective temperaments ; depressive disorders ; bipolar disorders ; youth ; heart rate variability ; polyvagal theory ; neurovisceral integration model ; emotional regulation ; psychopathology ; prefrontal functions ; exercise addiction ; alexithymia ; body image ; self-esteem ; COVID-19 vaccine ; vaccine acceptance ; vaccine intention ; aging ; cerebellum ; classification ; cognitive decline ; diadochokinesia ; motor control ; sensory motor performance ; time perception ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: histoire ; chirurgie ; histoire de la médecine ; différenciation sexuelle ; opération chirurgicale ; anthropologie ; ages de la vie ; bic Book Industry Communication::J Society & social sciences::JH Sociology & anthropology::JHM Anthropology ; bic Book Industry Communication::M Medicine ; thema EDItEUR::J Society and Social Sciences::JH Sociology and anthropology::JHM Anthropology ; thema EDItEUR::M Medicine and Nursing

Keywords: multiple sclerosis ; genetics ; disease modifying therapies ; generic medicines ; association study ; reactive oxygen species ; NADPH oxidase ; CYBB ; autoimmunity ; axon ; cortex ; demyelination ; mitochondria ; myelin ; neurodegeneration ; oligodendrocyte ; progressive multiple sclerosis ; daclizumab ; relapsing multiple sclerosis ; CD25 ; innate immune system ; interleukin-2 ; drug reaction with eosinophilia systemic symptoms ; DRESS ; monoclonal antibodies ; anti-CD20 ; Ocrevus ; Rituxan ; Tysabri ; clinical trial ; disease modifying therapy ; demyelinating diseases ; cognitive impairment ; cognitive dysfunction ; stem cells ; autologous hematopoietic ; mesenchymal ; neuronal ; induced pluripotent ; human embryonic ; pregnancy ; post-partum ; treatment ; neuromyelitis optica spectrum disorders ; anti-MOG syndrome ; aquaporin 4-IgG ; myelin oligodendrocyte glycoprotein ; remyelination ; outcome measures ; biomarkers ; bic Book Industry Communication::M Medicine

Keywords: carpal tunnel syndrome ; support vector machine ; machine learning ; tablet app ; screening ; manual dexterity ; drawing ; nerve ; pain ; mobility ; ESWT ; corticosteroid ; gabapentin ; Kinesio taping ; orthoses ; platelet-rich plasma ; neurodynamic techniques ; ultrasound ; splint ; entrapment neuropathy ; conditioned pain modulation ; temporal summation ; pain measurement ; pressure pain threshold ; central sensitization ; central sensitization inventory ; neuropathy ; revision carpal tunnel release ; neurolysis ; body mass index ; waist circumference ; waist-to-hip ratio ; obesity ; median nerve ; diabetic neuropathy ; diabetes ; nerve conduction study ; electrophysiological severity classification ; electrodiagnosis ; X-rays ; ultrasonography ; diabetes mellitus ; peripheral nerve ultrasound ; carpal tunnel release ; wide-awake anesthesia ; local anesthesia ; WALANT ; nerve compression ; carpal tunnel surgery ; ulnar nerve entrapment ; cubital tunnel syndrome ; psychotropic drugs ; psychological health ; socioeconomical factors ; national quality register ; median neuropathy ; median nerve entrapment ; neuralgic amyotrophy ; pronator syndrome ; trends ; Japan ; n/a ; bic Book Industry Communication::M Medicine

Keywords: inflammation ; chronic kidney disease ; anemia ; anemia of inflammation ; ESA hyporesponsiveness ; renal tubular epithelial cells ; macrophages ; lipocalin-2 ; iron ; cilastatin ; hypoxia inducible factor-1-α ; ischemia-reperfusion injury ; acute kidney injury ; cyclophilin A ; fibrosis ; renal fibrosis ; tubular necrosis ; preeclampsia ; podocytes ; VEGF ; FSGS ; proteinuria ; endocan ; ESM-1 ; renal replacement therapy ; kidney transplantation ; biomarker ; diabetic nephropathy ; focal segmental glomerulosclerosis ; innate immunity ; membranous nephropathy ; minimal change diseases ; TLR ; NOX1 ; ML171 ; reactive oxygen species ; ERK ; T cells ; glomerulonephritis ; chemokines ; renal disease ; DJ-1 ; ND-13 ; renal inflammation ; oxidative stress ; UUO ; autophagy ; apoptosis ; trehalose ; simvastatin ; endotoxin ; tubular apoptosis ; cytochrome C ; Bcl-XL ; survivin ; hypercholesterolemia ; xanthine oxidase ; NF-κB pathway ; tertiary lymphoid organs ; B cells ; BAFF ; kidney fibrosis ; myofibroblast activation ; extracellular matrix ; Hippo pathway ; verteporfin ; IgAN ; CKD ; progression ; ACEI ; corticosteroids ; costimulation ; coinhibition ; kidney transplant ; SPR ; protein binding affinity ; adaptive immunity ; epithelial-to-mesenchymal transition ; E. cava extracts ; dieckol ; spontaneously hypertensive rats ; angiotensin II ; n/a ; bic Book Industry Communication::M Medicine

Keywords: protein ; structure ; and ; regulation ; scaffolding ; complex ; formation ; cellular ; signalling ; non-canonical ; substrates ; inhibition ; targeting ; biological ; function ; bic Book Industry Communication::M Medicine

Keywords: insulin secretory granule ; beta-cells ; granule protein purification ; free fatty acid receptor (FFA) 2 ; FFA3 ; gut microbiome ; incretin ; insulin secretion ; short-chain fatty acids ; type 1 diabetes ; cytosolic calcium concentration ; glucose ; metabolic amplification ; mitochondria ; nutrient secretagogues ; diabetes ; hypoglycemic unaware ; ischaemia ; islet cell transplantation ; organ donation ; pancreas ; insulin ; beta cell ; human ; islet ; polarisation ; machine learning ; deep learning ; cell segmentation ; automation ; pancreatic islets ; leptin ; exocytosis ; tissue-engineering ; in vivo imaging ; metabolism ; β-cell ; viral transduction ; transplantation ; amplifying pathway ; hyperglycemia ; adenylyl cyclase ; incretins ; glucokinase ; forskolin ; cAMP ; exenatide ; islets ; bioenergetics ; glucose-stimulated insulin secretion ; respiration ; advanced glycation end products ; alagebrium chloride ; cross-link breaker ; immunopeptidome ; MIN6N8 cell line ; NOD mouse ; autoimmune diabetes ; pancreatic beta-cells ; intrauterine growth restriction ; maternal obesity ; developmental programming ; islet amyloid polypeptide (IAPP) ; granin ; secretory pathway ; trans-Golgi network (TGN) ; granule ; pancreatic β-cell ; amino acid ; aminoaciduria ; diabetes incidence ; insulitis ; neutral amino acid transporter ; non-obese diabetic mouse ; pancreatic islet ; Slc6a19 deficiency ; n/a ; bic Book Industry Communication::M Medicine

Keywords: electrocardiographic imaging (ECGI) ; heart failure (HF) ; cardiac resynchronization therapy (CRT) ; ultrasound ; strain ; speckle tracking echocardiography ; in silico ; electrophysiology ; electrocardiogram ; ECG ; cardiac disease ; arrhythmia ; ischemia ; standardization ; computerized ECG ; personalized medicine ; telemedicine ; digital ECG data interchange protocol ; eHealth ; ECG equipment ; computerized electrocardiograph ; ECG analysis algorithms ; computerized ECG interpretation ; interatrial block ; partial interatrial block ; advanced interatrial block ; atypical patterns ; electrocardiogram (ECG) ; automated ECG analysis ; CSE study ; age ; sex ; race ; historical aspects ; electronic cohort ; mortality ; big data ; telehealth ; alarm fatigue ; annotation of ECG data ; arrhythmia alarms ; intensive care unit ; patient monitoring ; ambulatory ECG ; machine learning ; deep learning ; pattern recognition ; noise reduction ; Holter ECG ; ECG interpretation ; artificial intelligence ; body surface mapping ; electrocardiographic imaging ; image processing ; clinical applications ; n/a ; bic Book Industry Communication::M Medicine

Keywords: multiple myeloma ; immunotherapy ; daratumumab ; BCMA ; bi-specific T cell engagers ; chimeric antigen receptor ; relapse ; cytokine-release syndrome ; allogeneic transplantation ; myeloablative ; non-myeloablative ; new drugs ; CAR T ; antibodies ; monoclonal ; bispecific ; immunoconjugates ; antibody-drug conjugates ; myeloma ; NK cells ; immunomodulation ; cell therapy ; graft-versus-myeloma ; donor lymphocyte infusion ; allogeneic stem cell transplantation ; prophylaxis ; salvage ; CAR T-cells ; target antigen ; n/a ; bic Book Industry Communication::M Medicine

Keywords: quantum dots (QDs) ; DNAzyme ; ROS ; Amplex Red ; light-induced activity ; DNA methylation ; histone code ; microRNA ; nanoparticles ; noncoding RNA ; pulmonary arterial hypertension ; aptamer ; aptasensor ; influenza ; SERS ; virus detection ; α-synuclein ; antisense oligonucleotide ; dopamine neurotransmission ; double mutant A30P*A53T* ; motor deficits ; Parkinson’s disease ; transgenic mouse model ; G-quadruplexes ; covalent dimer construct ; anti-proliferative activity ; primary cell culture of human glioma ; antisensense oligonucleotide ; Foxp3 ; regulatory T cells ; vaccine immunogenicity ; Sporothrix schenckii ; Marfan syndrome ; fibrillin-1 ; antisense oligonucleotides ; exon skipping ; splice-switching ; bic Book Industry Communication::M Medicine

Keywords: flavonoids ; inflammation ; p53 ; cancer prevention ; Nrf2 pathway ; anti-oxidant ; verbascoside ; polyphenols ; insulin-producing cells ; diabetes ; UPR ; oxidative stress ; ER-stress ; PERK ; anti-inflammatory ; mitochondria ; antioxidants ; marine algae ; anti-viral activity ; mechanism of action ; Antirhea borbonica ; kidney fibrosis ; caffeic acid ; antioxidant enzymes ; DESI-imaging ; curcumin ; glioblastoma cells ; radiation ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: dementia ; behavioral and psychological symptoms of dementia ; systematic review ; meta-analysis ; animal-assisted intervention ; pet-robot intervention ; G protein-coupled receptors ; GPR120 ; FFAR4 ; schizophrenia ; polyunsaturated fatty acids ; long-chain fatty acids ; omega-3 ; nutritional psychiatry ; Alzheimer’s disease ; psychiatric disease ; depression ; anxiety ; Down’s syndrome ; inositol ; nutraceutical ; insulin signaling ; antioxidant ; aging ; psilocybin ; clinical trials ; oxidative stress ; redox ; multiple sclerosis ; biomarker ; neurodegenerative disease ; personalized medicine ; major depressive disorder ; longitudinal study ; LC-MS/MS ; plasma protein biomarker ; drug response monitoring ; multiple reaction monitoring ; diabetes mellitus ; type 2 ; dyslipidemias ; hypertension ; post-stroke depression ; disability level ; mortality ; late-life depression ; neuroimaging ; resting-state functional magnetic resonance imaging ; default mode network ; executive control network ; salience network ; healthy life expectancy (HALE) ; morbidity/mortality paradox ; cognition ; systolic blood pressure ; cerebral blood flow ; arterial properties ; angiogenesis ; gender medicine ; neurodegenerative disorders ; kisspeptin ; locomotion ; Kiss1 receptor ; HPA axis ; HPG axis ; nucleus accumbens ; stroke ; lipid ; diabetes ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine

Keywords: IVM ; oocytes ; equine ; metabolomic ; embryo transfer ; reproductive fluids ; pregnancy ; vitrification ; calving ; selection programme ; embryo vitrification ; Gompertz growth curve ; biobanking ; reproductive performance ; stallion sperm ; capacitation ; penicillamine ; thermotaxis ; selection ; BMP15 ; ram ; semen ; semen freezing ; semen extender ; stallions ; semen quality ; fertilizing ability ; Tris ; boar spermatozoa ; perfluorinated compounds ; PFHxS ; PFOS ; spermatozoa toxicology ; glucocorticoid receptor ; gene expression ; RT-qPCR ; seminal plasma ; female genital tract ; rabbit ; spermatozoa ; oocyte ; in vitro fertilization ; extracellular vesicles ; assisted reproductive technologies ; embryo ; oocyte competence ; livestock production ; assisted reproductive technology ; embryo development ; micromanipulation ; in vitro production ; nanoparticles ; liposomes ; exosomes ; cryopreservation ; sheep ; ovary storage ; transport ; in vitro embryo production ; sperm selection ; chemotaxis ; IVF ; IVC ; porcine ; cryopreserved sperm ; sperm–oviduct interaction ; ARTs ; equines ; horse ; sperm ; red light irradiation ; extender ; straw ; bic Book Industry Communication::M Medicine

Keywords: milk intake ; mortality ; stroke ; Bayesian survival anlysis ; time-to-event data ; JACC study ; unhealthy eating habits ; accumulation ; obesity ; central obesity ; general Japanese population ; atherosclerotic cardiovascular disease ; polyunsaturated fatty acids ; eicosapentaenoic acid ; docosahexaenoic acid ; arachidonic acid ; descriptive study ; heart failure ; vitamin D ; big data ; heart failure with preserved ejection fraction ; geriatric nutritional risk index ; behavioral modification stages ; nutrition counseling ; patient education ; acute coronary syndrome ; healthy behaviors ; diet ; legumes ; fish ; red/processed meat ; physical activity ; anxiety ; depression ; season ; calorie intake ; hospitalization ; malnutrition ; D-dimer ; intervention ; elderly ; cardiovascular mortality ; selenium ; coenzyme Q10 ; acylcarnitine ; brain natriuretic peptide ; cardiac function ; cardiomyopathy ; carnitine deficiency ; CPT2 ; end-stage kidney disease ; free fatty acid ; hemodialysis ; continuous glucose monitoring ; glucose fluctuation ; intracranial artery stenosis ; mean amplitude of glycemic excursions ; standard deviation ; palliative care ; end-of-life care discussion ; advance care planning ; food intake ; artificial nutrition ; onco-cardiology ; nutrition status ; cancer ; acute myocardial infarction ; plant-based dietary patterns ; grains ; nuts ; fruits ; vegetables ; cardiovascular disease ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: Medicina ; Biologia ; Chimica ; bic Book Industry Communication::M Medicine

Keywords: COVID-19 ; SARS-CoV-2 ; interleukin-6 ; tocilizumab ; therapy ; coronavirus disease 2019 ; cytokines ; severity ; prognosis ; mortality ; kidney failure ; rapid diagnostic test ; antigen detection ; Cytomegalovirus ; co-infections ; critical care ; liver markers ; inflammation ; morbidity ; personalized medicine ; liver functional tests ; COVID-19 pneumonia ; meta-analysis ; trial sequential analysis ; children ; clinical presentation ; coronavirus disease 2019 (COVID-19) ; epidemiology ; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ; clinical outcome ; symptomatology ; pandemic ; angiotensin 1 receptor (AT1R) ; AT1R concentration ; angiotensin II ; symptoms’ severity ; diagnosis ; artificial intelligence ; medical imaging ; systematic umbrella review ; methodological credibility ; PCR test ; COVID-19 diagnosis ; Charlson Comorbidities Index ; cluster analysis ; longitudinal cluster ; individualized management ; n/a ; bic Book Industry Communication::M Medicine

Keywords: eye ; retina ; development ; vascularization ; hypoxia ; autophagy ; programmed cell death ; cellular senescence ; retinogenesis ; altricial bird species ; precocial bird species ; senescence-associated galactosidase activity ; diabetes mellitus ; retinopathy ; microvascular ; complication ; optical coherence tomography ; angiography ; black ; African-American ; systemic disease ; biomarker ; retinal degenerative diseases ; mesenchymal stem cells ; stem cell therapy ; experimental models ; clinical trials ; AMD ; age-related macular degeneration ; trichostatin A (TSA) ; HDAC ; histone deacetylase ; vascular endothelial growth factor (VEGF) ; retinal degeneration ; endoplasmic reticulum ; stress response ; unfolded protein response ; GRP78 ; retinal glial cell ; diabetic retinopathy ; zebrafish ; neurovascular unit ; microvascular complications and dysfunction ; metabolism ; motor protein ; myosin 1C ; photoreceptor ; rhodopsin ; outer segments ; visual function ; macroglia ; astrocytes ; Müller cells ; optic nerve crush ; retinal ganglion cells ; spinal cord injury ; signal transducer and activator of transcription 3 ; epidermal growth factor ; Drp1 ; apoptosis ; mitochondria ; microglia ; neurodegeneration ; multiple sclerosis ; retinal microglia ; microglia morphotype ; light damage ; functional analysis ; early detection ; remodeling ; lactate ; GPR81 ; HCAR1 ; growth cone ; dLGN ; axon ; 3,5-DHBA ; kallikrein-kinin system ; kinin receptors ; GFAP ; osteopontin ; retinal detachment ; diabetes ; antioxidants ; bioenergetics ; respiration ; ATP ; glucagon-like peptide-1 ; exendin-4 ; catalase ; immunohistochemistry ; electron microscopy ; Charles Bonnet syndrome ; EEG ; visual hallucination ; resting state ; high-fat diet ; gut microbiome ; gut-retina axis ; RNA sequencing ; germ-free mice ; complement cascade ; angiogenesis ; retinal inflammation ; AII amacrine cell ; Prox1 ; parvalbumin ; gap junction ; eccentricity ; ON/OFF asymmetry ; arterioles ; betulinic acid ; ischemia-reperfusion injury ; reactive oxygen species ; retinal vessels ; retinal fluorescence imaging ; amyloid ; cognitive decline ; Alzheimer’s disease ; optic neuritis ; oxidative stress ; neuroprotection ; fingolimod ; iPSC-RPE ; retinal pigment epithelium ; immunodeficient RCS rat ; ultrathin parylene ; retinal transplantation ; CD4+CD25+ ; inflammation ; iPSC ; typical cannabinoid receptors ; atypical cannabinoid receptors ; electroretinography ; monkeys ; visual system ; eye inflammation ; lipopolysaccharide ; natural bioactive extracts ; Ac2-26 ; FPR receptor ; inflammatory mediators ; retinal light injury ; LED screen ; optical filter ; retinal protection ; regeneration ; progenitor cell ; hyperglycemia ; photoreceptors ; neurod ; Notch ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: hepatic steatosis ; single nucleotide polymorphism ; HBs antigen ; sequential therapy ; bile duct cancer ; cholangioscope ; genetic mutation ; tumor spread ; biopsy ; hepatocellular carcinoma ; WFA±M2BP ; AFP ; chronic hepatitis C ; direct-acting antivirals ; autotaxin ; hepatitis C virus ; sustained viral response ; Wisteria floribunda agglutinin positive Mac-2 binding protein ; let-7 family ; miRNA ; biomarker ; HBV ; HCV ; HIV ; acute liver failure ; nonalcoholic fatty liver diseases ; NASH ; GRP78 ; liver fibrosis ; hepatic stellate cells ; TGF-β ; JNK signaling pathway ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine::MJC Diseases & disorders

Keywords: Escherichia coli ; antimicrobial resistance ; swine ; weaned piglet ; antibiotic growth promoters ; antibiotic ; antibiotic resistance ; livestock ; antibiotic use ; AMR ; MDR ; environment ; antimicrobial usage ; bovine ; India ; KAP survey ; veterinarians ; antimicrobial use ; antimicrobial resistance (AMR) ; Timor-Leste ; antimicrobial ; veterinary ; prudent use ; critically important antimicrobials ; growth promotion ; poultry ; sheep ; beef cattle ; normalised resistance interpretation ; antimicrobial susceptibility testing ; tetracyclines ; farms ; turkeys ; farm ; antimicrobial resistance genes ; biosecurity ; risk factor ; metagenomics ; qPCR ; isolates ; neonatal calf diarrhea ; survey ; antibiotics ; HPCIA ; urinary tract infection ; Flexicult Vet ; pathogen identification ; dogs ; cats ; veterinary microbiology ; bovine respiratory disease ; multidrug-resistance ; Pasteurella multocida ; Mannheimia haemolytica ; Truperella pyogenes ; dairy farm ; E. coli ; calves ; enteritis ; serotypes ; virulence ; multidrug-resistant ; extensively drug-resistant ; dairy ; ESBL ; MRSA ; dog ; canine parvovirus ; Carnivore protoparvovirus 1 ; multidrug resistance ; One Health ; Enterobacteriaceae ; public awareness ; farmworkers ; chicken ; growth promoters ; Staphylococcus hyicus ; PFGE ; exudative epidermitis ; pigs ; monitoring ; carbapenems ; CPE ; meat-producing animal ; companion animal ; travelers ; feed ; risk assessment ; introduction risk ; stochastic risk model ; coagulase-negative Staphylococcus ; CoNS ; quails ; broilers ; bic Book Industry Communication::M Medicine

Keywords: autism spectrum disorder ; infants ; frontal EEG alpha asymmetry ; early detection ; autism spectrum disorders ; toddlers ; eye tracking ; joint attention ; longitudinal ; regression ; cytokines ; PAI-1 ; neuroinflammation ; gastrointestinal ; autism ; literature review ; comorbidity ; early intervention ; early intensive behavioral intervention ; behavioral intervention ; First Year Inventory ; early screening ; risk ; cross-cultural generalisability ; validity ; preschool teachers ; self-efficacy ; knowledge ; belief ; skills ; identify ; autism spectrum disorder (ASD) ; level 1 and level 2 screening tools ; systematic review ; COSMIN ; PRISMA ; screening ; infection ; prion ; meta-analysis ; motion analysis ; video signal processing ; neurodevelopmental disorders ; infant screening ; n/a ; developmental language disorder ; semantic features ; word learning ; central coherence ; biomarker ; p-cresol ; mouse social behavior ; dopamine ; ASD ; vision ; proprioception ; self-motion ; immersive virtual reality ; IVR ; HMD ; technology ; persuasive text writing ; perspective-taking ; adolescence ; intervention ; sign language ; imitation ; cognition ; language acquisition ; prevalence estimate ; predictors ; surveillance review ; Autism Spectrum Disorder (ASD) ; early intensive intervention ; developmental trajectories ; moderators and mediators of intervention. ; psychosis ; schizophrenia ; psychopathology ; AQ ; accuracy ; attention to detail ; self-awareness ; insight ; preconception risk factor ; Gilles de la Tourette ; obsession ; compulsion ; social behavior ; social impairment ; sensory profile ; sensory responsiveness ; feeding problems ; short sensory profile (SSP) ; sensory experience questionnaire (SEQ) ; coronavirus ; 2019-nCoV ; neurodevelopment ; child and adolescent psychiatry ; mental health prevention ; Asperger syndrome ; adults ; cerebrospinal fluid ; antibodies ; blood–brain barrier ; GAD65 ; Early Start Denver Model ; high-risk infants ; motor development ; high-functioning autism ; language ; experience ; communication ; autonomic nervous system ; wearable technologies ; EEG ; theory of mind ; adults and adolescents ; human figure drawings ; Draw-a-Man ; drawings maturity ; social perception ; ERP ; reward response ; RewP ; sensitization ; social skills intervention ; PEERS® ; adulthood ; diagnosis ; autistic traits ; action observation ; action prediction ; context ; priors ; hypothalamus ; amygdala ; oxytocin ; social cognition ; social interaction ; affiliative behavior ; neuroimaging ; COVID-19 ; challenging behavior ; dental care ; oral health ; medical procedures ; ICT ; wearable sensors ; migration ; Europe ; health system ; autism in adulthood ; intellectual disability ; regressive autism ; epilepsy ; challenging behaviors ; empathy ; executive functions ; attention deficit and hyperactivity disorder ; disruptive behavior disorders ; alexithymia ; anxiety ; depression ; TAS-20 ; TSIA ; parents ; broader autism phenotype ; autistic-like features ; social-cognitive development ; stereotypical behaviors ; visual impairment ; language profiles ; grammatical comprehension ; cannabinoids ; cannabidiol ; cannabidivarin ; THC ; problem behaviors ; sleep ; hyperactivity ; side effects ; motor performance skills ; Gulf ; BOT-2 ; machine learning ; employment ; telehealth ; ABA ; RCT ; cortisol ; group activity ; stress ; art ; assessment ; sensorimotor integration ; postural balance ; false positive report probability (FPRP) ; Bayesian false-discovery probability (BFDP) ; Genome-Wide Association Studies (GWAS) ; microbiome ; metabolomics ; study design ; biomarker discovery ; precise medicine ; bipolar disorder ; suicidal ideation ; suicidal attempts ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: monoclonal antibody ; NSCLC ; immunotherapy ; ELISA ; pharmacokinetics ; pharmacogenetics ; anti-PD-1 monoclonal antibodies ; anti-acetylcholine receptor (AChR) antibody ; B cell ; immune checkpoint blockade ; immune-related adverse events (irAEs) ; myasthenia gravis (MG) ; non-small-cell lung cancer (NSCLC) ; nivolumab ; programmed cell death ligand 1 (PD-L1) ; T cell ; tetraspanins ; cancer ; Tspan8 ; radioimmunotherapy ; immune-checkpoint inhibitors ; LDH ; biomarkers ; Ang-2 ; antiangiogenic therapy ; in vivo imaging ; radio- and chemotherapy ; VEGF-A ; cancer therapy ; neovascularization ; angiogenesis ; tumor microenvironment ; colorectal cancer ; antibody ; NK cells ; ADCC ; CD133 ; prominin-1 ; gold nanoparticles ; antibody-drug conjugates ; cell penetrating peptide ; HIV-1 TAT ; active-targeting ; targeted delivery ; trastuzumab ; MMAE ; valine-citrulline ; affibody ; drug conjugates ; hepatic uptake ; DM1 ; dermatooncology ; immune checkpoints ; monoclonal antibodies ; passive immunotherapy ; canine B-cell lymphoma ; DLA-DR ; HLA-DR ; antibody-drug conjugate ; ADC ; methotrexate ; tumor immunity ; combination therapy ; multiple myeloma (MM) ; monoclonal antibodies (mAbs) ; antibody products ; B cell maturation antigens (BCMAs) ; bispecific T cell engagers (BiTEs®) ; checkpoint inhibitors 1 ; protein structure 2 ; pharmacokinetics 3 ; drug optimization 4 ; HER2-positive breast cancer ; metastatic disease ; neoadjuvant and adjuvant therapy ; targeted therapy ; acute myeloid leukemia ; CD123 ; IL3RA ; kinesin spindle protein inhibitor ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KND Manufacturing industries::KNDP Pharmaceutical industries

Keywords: dairy cow ; fatty liver ; lipid metabolism ; oxidative stress ; SIRT1 ; dairy cows ; PPARγ ; non-alcoholic fatty liver disease (NAFLD) ; genetic factor ; dairy industry ; milking system ; work routine ; parlor ; milking model ; small dairy ; reproductive strategy ; parity ; season ; rank of AI ; type of AI ; heat stress ; whole transcript sequencing ; immune response ; stress response ; myostatin gene ; variation ; milk ; fatty acid ; cattle ; milk production ; metabolomics ; biomarkers ; flaxseed ; dry period ; enterolactone ; milk fatty acids ; peak of lactation ; lipolysis ; fatty acids ; casein ; postpartum diseases ; activin ; inhibin ; cytokines ; endometrium ; subclinical endometritis ; cow ; milk beta-hydroxybutyrate ; fat to protein content ratio ; left displaced abomasum ; negative energy balance ; alpha-tocopherol/vitamin E-related gene ; calving ; colostrum ; high-yield dairy cows ; inflammation ; health ; lactation ; liver ; mammary gland ; ultrasonography ; pregnancy proteins ; embryonic mortality ; fetal mortality ; body condition score ; urea ; β-hydroxybutyrate ; metabolism ; urea in milk ; primiparous cows ; lactation curves ; feeding system ; herd management ; protein metabolism ; amino acids ; milk protein ; Saccharomyces cerevisiae ; high-yield cows ; pH ; VFA ; inflammatory cytokines ; transition period ; ketosis ; RNA-Seq ; clustering ; liver metabolism ; Jersey ; oral calcium bolus ; calcium ; hypocalcemia ; mastitis ; culling ; reproduction ; herd health ; milking management ; production systems ; bic Book Industry Communication::M Medicine

Keywords: antibiotic resistance ; virulence factors ; Klebsiella pneumoniae ; photodynamic therapy ; cyanine dyes ; cancer therapy ; irradiation ; antimicrobial photodynamic therapy ; periodontitis ; scaling and root planing ; systematic review ; meta-analysis ; colon carcinoma cells ; stress responses ; candidiasis ; C. albicans ; methylene blue ; tetraether liposomes ; nebulisation ; liposomal stability ; curcumin ; A549 cells ; PDT mechanisms ; new photosensitizers ; PDT tumor treatment ; antimicrobial PDT ; non-oncologic applications of PDT ; PDT in medical devices ; photosensitizers ; liposomes ; stealth liposomes ; thermosensitive liposomes ; tetraether lipids ; cancer ; methicillin-resistant Staphylococcus aureus ; hypericin ; wound infection model ; targeted delivery ; head and neck cancer ; nanoparticles ; 5-aminolevulinic acid ; ALA-based photodynamic therapy ; phototherapy ; extracorporeal ; photopheresis ; chronic graft-versus-host disease ; light ; malignant tumors ; nanomedicine ; natural photosensitizer ; photobiomodulation (PBM) ; photodynamic therapy (PDT) ; porphyrins ; fluorescence lifetime imaging miscroscopy (FLIM) ; antimicrobial photodynamic therapy (aPDT) ; Helicobacter pylori biofilm ; experimental arthritis ; multi-drug resistance ; antibiotic synergy ; dental caries ; oral biofilms ; Fotoenticine ; chlorine ; antimicrobials ; ROS ; combinatory strategies ; multidrug resistance ; wound healing ; low-dose photodynamic therapy ; photosensitizer ; two-photon microscopy ; second-harmonic-generation-to-auto-fluorescence aging index of the dermis ; actinic keratosis ; physcion ; hydroxypropyl-β-cyclodextrin ; low dose photodynamic therapy ; optical coherence tomography ; aggregation-induced emission ; organelles targeting ; hepatocellular carcinoma ; viral inactivation ; photodynamic inactivation ; SARS-CoV-2 pseudovirus ; enveloped virus ; UV-C light ; antimicrobial nanomaterials ; carbon nanotubes ; graphene ; magnetic nanoparticles ; hydrogel ; photothermal therapy ; nanocarrier ; actinic keratoses ; combination ; topical ; systemic ; laser ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KND Manufacturing industries::KNDP Pharmaceutical industries

Keywords: COVID-19 ; SARS-CoV-2 ; hepatitis B and C ; cirrhosis ; chronic kidney disease ; alcohol-related liver disease ; nonalcoholic steatohepatitis ; necrosis ; MDR-TB ; clinical trials ; IL-6 inhibitors ; tocilizumab ; cytokine release syndrome ; cytokine storm ; operational research ; health systems ; SORT IT ; pandemics ; training ; pandemic ; endemic ; tuberculosis ; impact ; control ; overview ; malaria ; preparedness ; Africa ; emergency ; fecal calprotectin ; bowel perforation ; D-Dimer ; thrombosis ; ischemia ; efficacy ; safety ; kaletra ; lopinavir/ritonavir ; meta-analysis ; coronavirus ; SARS-CoV-1 ; MERS ; SARS ; influenza ; healthcare worker ; healthcare personnel ; general practitioners ; medical doctor ; heart transplant ; CMV ; Chagas disease ; infection ; severity ; respiratory viruses ; coinfections ; health care workers ; Philippines ; rhinovirus ; severe acute respiratory syndrome coronavirus 2 ; plasmodium falciparum ; differential diagnosis ; cognitive bias ; diagnostic reasoning ; recurrence ; reinfection ; Bangladesh ; Kenya ; Nairobi ; presumptive tuberculosis ; TB treatment outcomes ; HIV ; antiretroviral therapy ; EpiCollect5 ; Malawi ; Lilongwe ; Zimbabwe ; Harare ; real-time operational research ; ethics ; research capacity building ; India ; Nepal ; post-acute COVID-19 syndrome ; COVID-19 vaccines ; mortality ; epidemiology ; public health ; healthcare workers ; attitudes ; perceptions ; knowledge ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMR Environmental medicine

Keywords: Biologia ; Storia ; Scienze naturali ; bic Book Industry Communication::M Medicine

Keywords: diabetes mellitus ; cluster analyses ; risk factors ; micro- and macrovascular disease ; hyperuricemia ; sex ; renal progression ; chronic kidney disease ; disability ; children ; oral health ; caries ; dental treatment ; personalized medicine ; precision medicine ; Covid-19 ; SARS CoV2 ; epidemiology ; host genetics ; viral genome ; early diagnosis ; type 1 diabetes mellitus ; COVID-19 ; epidemics ; diabetic ketoacidosis ; hypertension and type 2 diabetes mellitus comorbidity ; IgG ; N-glycosylation ; biomarkers ; tongue pressure ; aging ; community ; elderly ; tuberculosis ; pulmonary function ; respiratory symptoms ; quality of life ; hepatitis C virus ; diffuse large B-cell lymphoma ; survival ; fibrosis ; performance status ; liver toxicity ; abdominal adiposity ; adolescents ; blood pressure ; obesity ; Jordan ; boys ; lung cancer screening ; smoking ; willingness to screen ; education ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MM Other branches of medicine::MMG Pharmacology

Keywords: pharmacy ; conference ; anniversary ; science ; Charles University ; Hradec Králové ; bic Book Industry Communication::M Medicine

Keywords: spumavirus ; feline illness ; proviral load ; neglected virus ; bovine foamy virus ; infectious clone ; particle release ; cell-free transmission ; foamy virus ; spumaretrovirus ; cross-species virus transmission ; zoonosis ; restriction factors ; immune responses ; FV vectors ; virus replication ; latent infection ; feline foamy virus ; epidemiology ; retrovirus ; Spumaretrovirus ; mountain lion ; Puma concolor ; ELISA ; protease ; reverse transcriptase ; RNase H ; reverse transcription ; antiviral drugs ; resistance ; simian foamy virus ; gibbon ; lesser apes ; co-evolution ; complete viral genome ; equine foamy virus ; isolation ; Japan ; sero-epidemiology ; reptile foamy virus ; endogenous foamy virus ; endogenous retrovirus ; ancient retroviruses ; co-speciation ; foamy virus-host interactions ; viral tropism ; infection ; kidney ; cats ; chronic kidney disease ; chronic renal disease ; integrase ; integration ; co-infections ; NHP ; pathogenesis ; zoonoses ; viral prevalence ; Neotropical primates ; free-living primates ; Brazil ; new world primates ; simian retrovirus ; BFV ; spuma virus ; model system ; animal model ; animal experiment ; miRNA function ; gene expression ; antiviral host restriction ; gene therapy ; in-vivo gene therapy ; hematopoietic stem and progenitor cells ; foamy virus vector ; pre-clinical canine model ; SCID-X1 ; innate sensing ; cGAS ; STING ; foamy viruses ; wild ruminants ; European bison ; red deer ; roe deer ; fallow deer ; seroreactivity ; inter-species transmission ; HSC ; gene marking ; FV gene transfer to HSCs ; gene therapy alternatives ; serotype ; high-throughput sequencing ; replication kinetics ; cytopathic effect ; reverse transcriptase activity ; miRNA expression ; virus-host-interaction ; miRNA target gene identification ; innate immunity ; ANKRD17 ; Bif1 (SH3GLB1) ; replication in vitro ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::P Mathematics & science::PS Biology, life sciences::PSA Life sciences: general issues::PSAN Neurosciences

Keywords: n/a ; thyroid ; ultrasonography ; follicular neoplasm ; follicular lesion of unknown significance ; follicular thyroid cancer ; papillary thyroid carcinoma ; neoplasm metastasis ; biopsy ; fine-needle ; thyroglobulin ; US-guided minimally invasive techniques ; radiofrequency ablation ; RFA ; benign thyroid nodules ; thyroid cancer ; DTC recurrences ; PTMC ; long term ; follow-up ; regrowth ; classification system ; ultrasound classification system ; TIRAD ; nodule ; risk stratification ; TI-RADS ; fine-needle aspiration ; cancer ; ultrasound ; scintigraphy ; non-autonomously functioning ; thyroid imaging reporting and data systems (TIRADS) ; risk of malignancy (ROM) ; thyroid nodules ; paediatrics ; radiotherapy ; risk assessment ; DTC ; thyroid neoplasm ; medical imaging ; artificial intelligence ; machine learning ; deep learning ; radiomics ; prediction ; diagnosis ; Thyroid Imaging Reporting and Data Systems (TIRADS) ; pediatric thyroid nodules ; neck ultrasound ; contrast-enhanced ultrasound (CEUS) ; papillary thyroid cancer ; TIRADS ; thyroid nodule ; fine-needle aspiration biopsy ; elastosonography ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine

Keywords: clear cell renal cell carcinoma ; prognosis ; plasma ; PD-1 ; PD-L1 ; renal cell carcinoma ; immune checkpoint inhibitors ; immune related adverse events (irAEs) ; thyroid ; cutaneous ; biomarker ; DNA methylation ; epigenetics ; kidney ; hypoxia ; tumor microenvironment ; SCD-1 ; oleic acid ; renal cancer ; sunitinib ; resistance ; miRNA ; transcriptome ; pathway analysis ; nivolumab ; tissue slice culture ; PD1 ; T-cells ; metastatic clear cell renal cell carcinoma ; first-line treatment ; immunotherapy ; tyrosine kinase inhibitors ; combinations ; single-cell RNA sequencing ; immune landscape ; cancer immunotherapy ; intra-tumoral heterogeneity ; inter-tumoral heterogeneity ; inter-metastatic heterogeneity ; renal cell cancer ; treatment resistance ; angiogenesis ; adjuvant therapy ; prediction model ; prognostic factor ; clear cell kidney cancer ; radiogenomics ; radiomics ; machine learning ; gene expression ; cystic tumor ; imaging ; magnetic resonance ; surgery ; ddPCR ; circulating miRNA ; diagnosis ; malignancy ; histomorphological features ; PBRM1 ; immunohistochemistry ; architectural patterns ; endothelial cells ; translational ; immune checkpoint inhibitor ; responsiveness ; molecular features ; multisite tumor sampling ; intratumor heterogeneity ; clear-cell renal cell carcinoma ; disease progression ; prognostic factors ; biomarkers ; RNA sequencing ; n/a ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::M Medicine::MJ Clinical & internal medicine

Keywords: hypoxia ; transcriptome ; RNA-seq ; ChIP-seq ; public database ; meta-analysis ; peripheral blood cells ; blood-derived therapy ; angiogenesis ; platelet rich plasma (PRP) ; hypoxia preconditioned plasma ; hypoxia preconditioned serum ; transcription factor ; hypoxia-inducible factor 1 ; HIF-1 ; hypoxia sensing ; acetylsalicylic acid ; COX-1 ; clopidogrel ; drug anticoagulation ; NOACs ; oral anticoagulation ; VEGF ; adipose-derived stem cells ; adipose-derived cell supension ; lymphangiogenesis ; lymphatic regeneration ; macrophage ; matrix metalloproteinase ; atherosclerotic plaque rupture ; oxidative stress ; xanthine oxidase ; HIF ; T cells ; B cells ; monocytes ; macrophages ; neutrophils ; ILC ; oxygen ; HIF-PH inhibitor ; gene2pubmed ; bibliome ; signature genes ; GPR146 ; enrichment analysis ; n/a ; bic Book Industry Communication::M Medicine

Keywords: plasma half-life extension ; albumin conjugation ; in vivo glucose-lowering activity ; glucagon-like peptide-1 ; quality by design ; rapid equilibrium dialysis ; muco-adhesion ; brain PAMPA ; RPMI 2650 nasal epithelial cell ; human serum albumin ; dimerization ; doxorubicin ; enhanced permeability and retention effect ; antitumor ; Arthrobacter globiformis ; gout ; half-life extension ; inverse electron demand Diels-Alder reaction ; site-specific albumin conjugation ; thermostability ; urate oxidase ; albumin ; anti-thrombotic ; CD39 ; coating of medical devices ; stent coating ; therapeutic fusion protein ; conjugates ; vanadium ; cancer ; prodrug ; hydrogels ; EPR/ESR spectroscopy ; release behavior ; disulfide ; glioma ; conjugate ; albumin binding moieties ; peptides ; Evans blue ; 4-(p-iodophenyl)butyric acid ; integrin αvβ6 ; integrin αvβ6 binding peptide ; improved pharmacokinetics ; PET imaging ; bic Book Industry Communication::M Medicine ; bic Book Industry Communication::K Economics, finance, business & management::KN Industry & industrial studies::KND Manufacturing industries::KNDP Pharmaceutical industries

Keywords: endometriosis ; epigenetics ; EZH2 ; microRNA ; inflammation mediators ; annexin A1 ; Lipoxin A4 ; receptors ; Lipoxin ; Resolvin ; review ; ovarian cancer ; BMI-1 ; epithelial tumor cells ; stroma ; peritoneal fluid ; cytokines ; chemokines ; Th1 cells ; Th2 cells ; Treg cells ; Th17 cells ; long noncoding RNAs ; lncRNAs ; epithelial to mesenchymal transition ; EMT ; proliferation ; migration ; cytoskeleton ; dapsone ; DDS-NHOH ; red blood cell ; glycyrrhetinic acid ; endometrial cancer ; molecular basis of endometriosis ; human disease ; noncoding RNA (ncRNA) ; long noncoding RNA (lncRNA) ; circular lncRNA (circRNA) ; long non-coding RNAs ; sponging ; ceRNA ; chromatin ; chronic pain ; neurogenic inflammation ; neuroimmune modulation ; nerve signalling ; peripheral nerve ; inflammation ; non-hormonal treatment ; bic Book Industry Communication::M Medicine

Keywords: deep sea marine-derived fungus ; Myrothecium sp. ; myrothecol ; nitric oxide (NO) ; antioxidant activity ; macrolactam ; Deep-Sea-Derived Streptomyces ; abiotic formation ; natural product ; antifungal activity ; Thorectandra choanoides ; tryptophan alkaloid ; indoleamine 2,3-dioxygenase ; aplysinopsins ; GNPS molecular network ; cellular signal transduction ; bioactive metabolite ; deep-sea organisms ; anti-inflammatory agent ; anticancer agent ; Mariana Trench ; Micromonospora provocatoris MT25 ; desferrioxamine ; n-acetylglutaminyl glutamine amide ; 1H-15N 2D-NMR ; genomics ; biosynthetic gene clusters ; stress genes ; crustins ; antibacterial peptides ; hydrothermal vent ; anti-Gram-negative bacteria ; Al-crus 3 and Al-crus 7 ; Trichoderma ; harziane diterpenes ; NO inhibition ; thioester-containing benzoate ; deep-sea-derived fungus ; α-glucosidase inhibitory activity ; docking study ; bic Book Industry Communication::M Medicine

Keywords: papillary thyroid cancer ; SUV PET/CT ; BRAF V600E ; immune checkpoint inhibitors (ICIs) ; ipilimumab ; nivolumab ; prolactinoma ; Cushing’s disease ; aggressive pituitary tumor ; aggressive PitNET ; aggressive pituitary adenoma ; pituitary carcinoma ; adrenocortical cancer ; adrenal adenomas ; adrenal tumors ; p53 ; p27 ; ki-67 ; reticulin ; mitotane ; adjuvant treatment ; recurrence ; recurrence free survival ; timing ; intratumoral heterogeneity ; thyroid tumor ; BRAF ; RET/PTC rearrangements ; RAS mutation ; adrenal cortex ; carcinoma ; angiogenesis ; gene expression ; osteopontin ; hyaluronan synthase 1 ; multikinase inhibitors ; sorafenib ; lenvatinib ; differentiated thyroid cancer ; radioiodine resistance ; predictive marker ; predictors ; response to treatment ; survival ; information needs and preferences ; focus group interview ; personalized medicine ; neuroendocrine tumours ; phaeochromocytoma ; paraganglioma ; molecular clusters ; n/a ; bic Book Industry Communication::M Medicine